<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40770850</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0714</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of oral pathology &amp; medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology</Title><ISOAbbreviation>J Oral Pathol Med</ISOAbbreviation></Journal><ArticleTitle>Clinicopathological Study of Oncocytomas of Head and Neck Region: A Systematic Review.</ArticleTitle><Pagination><StartPage>635</StartPage><EndPage>646</EndPage><MedlinePgn>635-646</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jop.70022</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Salivary gland oncocytomas are infrequent benign salivary gland tumors with few reported cases.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study aimed to systematically review case reports and case series studies on oncocytomas in the head and neck region.</AbstractText><AbstractText Label="MATERIALS &amp; METHODS" NlmCategory="METHODS">Electronic searches were performed in PubMed, Scopus, Web of Science, Embase, and LILACS databases. The risk of bias was assessed using the Joanna Briggs Institute-University of Adelaide tool for case reports and case series.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 99 studies (145 cases) were included. Oncocytomas predominantly affected women, typically presenting as solitary, asymptomatic parotid masses in patients over 51&#x2009;years of age. Some cases reported multiple or bilateral tumors, occasionally associated with other salivary gland lesions. Histologically, the tumors were primarily composed of eosinophilic oncocytes with minimal pleomorphism, arranged in diverse architectural patterns. Immunohistochemical analysis revealed positivity for PTAH, antimitochondrial antigen, CK5/6, CK8/18, CK10/13, CK19, EMA, along with a low Ki67 index, while being negative for S100 and actin. Surgical excision was the primary treatment, with rare instances of recurrence.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Oncocytoma is a rare, benign neoplasm that most commonly arises in the parotid gland, with a predilection for female patients. Complete surgical excision constitutes the standard treatment and is associated with an excellent prognosis.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Journal of Oral Pathology &amp; Medicine published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Paiva</LastName><ForeName>Jo&#xe3;o Paulo Gon&#xe7;alves</ForeName><Initials>JPG</Initials><Identifier Source="ORCID">0000-0002-0079-2373</Identifier><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirschnick</LastName><ForeName>Laura Borges</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rold&#xe1;n</LastName><ForeName>Daniela Giraldo</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Manoela Domingues</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-8662-5965</Identifier><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Silva</LastName><ForeName>Alan Roger</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>Ciro Dantas</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Private Pathology Service, Get&#xfa;lio Sales Diagn&#xf3;sticos, GSD, Natal, Rio Grande do Norte, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorge</LastName><ForeName>Jacks</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Diagn&#xf3;stico Oral, Faculdade de Odontologia de Piracicaba, Universidade Estadual de Campinas, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>J Oral Pathol Med</MedlineTA><NlmUniqueID>8911934</NlmUniqueID><ISSNLinking>0904-2512</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018249" MajorTopicYN="Y">Adenoma, Oxyphilic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="Y">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012468" MajorTopicYN="Y">Salivary Gland Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">head and neck neoplasms</Keyword><Keyword MajorTopicYN="N">oxyphil cells</Keyword><Keyword MajorTopicYN="N">oxyphilic adenoma</Keyword><Keyword MajorTopicYN="N">salivary gland neoplasms</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>10</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40770850</ArticleId><ArticleId IdType="pmc">PMC12419982</ArticleId><ArticleId IdType="doi">10.1111/jop.70022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bullock M. J. and Jiang X. S., &#x201c;Top Ten Oncocytic Head and Neck Lesions to Contemplate,&#x201d; Head and Neck Pathology 17, no. 1 (2023): 53&#x2013;65, 10.1007/s12105-022-01520-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12105-022-01520-y</ArticleId><ArticleId IdType="pmc">PMC10063718</ArticleId><ArticleId IdType="pubmed">36928735</ArticleId></ArticleIdList></Reference><Reference><Citation>Baneckov&#xe1; M., Uro&#x2010;Coste E., Pt&#xe1;kov&#xe1; N., et&#xa0;al., &#x201c;What Is Hiding Behind S100 Protein and SOX10 Positive Oncocytomas?,&#x201d; Human Pathology 103 (2020): 52&#x2013;62, 10.1016/j.humpath.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2020.07.009</ArticleId><ArticleId IdType="pubmed">32673681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyde J., Takashima M., Dodson B., and Said S., &#x201c;Bilateral Multinodular Oncocytomas of the Parotid Arising in a Background of Bilateral Oncocytic Nodular Hyperplasia,&#x201d; Ear, Nose, &amp; Throat Journal 87, no. 1 (2008): 51&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357950</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastaran M. and Chandu A. B., &#x201c;Bilateral Submandibular Gland Oncocytoma in a Patient With Multiple Endocrine Neoplasia 2B Syndrome and Neurofibromatosis Type 1: An Unusual Case,&#x201d; International Journal of Oral and Maxillofacial Surgery 40, no. 7 (2011): 764&#x2013;767, 10.1016/j.ijom.2011.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijom.2011.02.017</ArticleId><ArticleId IdType="pubmed">21419601</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch E., Eilon A., Zelig S., and Ariel I., &#x201c;Synchronous Bilateral Oncocytoma of the Parotid Glands,&#x201d; ORL: Journal for Otorhinolaryngology and Its Related Specialties 46, no. 2 (1984): 66&#x2013;68, 10.1159/000275688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000275688</ArticleId><ArticleId IdType="pubmed">6700960</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson L. D., Wenig B. M., and Ellis G. L., &#x201c;Oncocytomas of the Submandibular Gland: A Series of 22 Cases and a Review of the Literature,&#x201d; Cancer 78, no. 11 (1996): 2281&#x2013;2287, 10.1002/(SICI)1097-0142(19961201)78:11&lt;2281::AID-CNCR3&gt;3.0.CO;2-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0142(19961201)78:11&lt;2281::AID-CNCR3&gt;3.0.CO;2-Q</ArticleId><ArticleId IdType="pubmed">8940996</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zakkoyunlu Has&#xe7;i&#xe7;ek S., &#x201c;Oncocytic Lesions of Salivary Glands With Morphological and Immunohistochemical Finding,&#x201d; Medical Bulletin of Sisli Etfal Hospital 54, no. 1 (2018): 88&#x2013;93, 10.14744/semb.2018.04935.</Citation><ArticleIdList><ArticleId IdType="doi">10.14744/semb.2018.04935</ArticleId><ArticleId IdType="pmc">PMC7192248</ArticleId><ArticleId IdType="pubmed">32377140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis G. L., &#x201c;&#x201c;Clear Cell&#x201d; Oncocytoma of Salivary Gland,&#x201d; Human Pathology 19, no. 7 (1988): 862&#x2013;867, 10.1016/S0046-8177(88)80271-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0046-8177(88)80271-5</ArticleId><ArticleId IdType="pubmed">3402976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada S., Fujiwara K., Hatakeyama H., and Homma A., &#x201c;Oncocytoma of the Parotid Gland With Facial Nerve Paralysis,&#x201d; Case Reports in Otolaryngology 2018 (2018): 1&#x2013;4, 10.1155/2018/7687951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/7687951</ArticleId><ArticleId IdType="pmc">PMC6032967</ArticleId><ArticleId IdType="pubmed">30034902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C. X. and Gao Y., &#x201c;Oncocytoma of the Salivary Glands: A Clinicopathologic and Immunohistochemical Study,&#x201d; Oral Oncology 45, no. 12 (2009): e232&#x2013;e238, 10.1016/j.oraloncology.2009.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oraloncology.2009.08.004</ArticleId><ArticleId IdType="pubmed">19796983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T., Lin Y., Lee W., Wu T., and Chang S., &#x201c;Malignant Transformation of a Benign Oncocytoma of the Submandibular Gland: A Case Report,&#x201d; Kaohsiung Journal of Medical Sciences 26, no. 6 (2010): 327&#x2013;332, 10.1016/S1607-551X(10)70047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1607-551X(10)70047-4</ArticleId><ArticleId IdType="pmc">PMC11915957</ArticleId><ArticleId IdType="pubmed">20538238</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberto P. L., Ashim S., Megan K., et&#xa0;al., &#x201c;Salivary Gland Oncocytomas: A Systematic Review,&#x201d; Head and Neck Pathology 18, no. 1 (2024): 126, 10.1007/s12105-024-01730-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12105-024-01730-6</ArticleId><ArticleId IdType="pmc">PMC11608208</ArticleId><ArticleId IdType="pubmed">39614964</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M. J., McKenzie J. E., Bossuyt P. M., et&#xa0;al., &#x201c;The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,&#x201d; BMJ 372 (2021): n71, 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnier J. J., Kienle G., Altman D. G., Moher D., Sox H., and Riley D., &#x201c;The CARE Guidelines: Consensus&#x2010;Based Clinical Case Reporting Guideline Development,&#x201d; Headache 53, no. 10 (2013): 1541&#x2013;1547, 10.1111/head.12246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.12246</ArticleId><ArticleId IdType="pubmed">24266334</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO , WHO Classification of Tumours: Head and Neck Tumors, 5th ed. (International Agency for Research on Cancer, 2022).</Citation></Reference><Reference><Citation>Martins&#x2010;Andrade B., dos Santos Costa S. F., Sant'ana M. S. P., et&#xa0;al., &#x201c;Prognostic Importance of the Lymphovascular Invasion in Head and Neck Adenoid Cystic Carcinoma: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Oral Oncology 93 (2019): 52&#x2013;58, 10.1016/j.oraloncology.2019.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oraloncology.2019.04.014</ArticleId><ArticleId IdType="pubmed">31109696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschnick L. B., Silveira F. M., Schuch L. F., et&#xa0;al., &#x201c;Clinicopathological Analysis of Oral and Maxillofacial Acinic Cell Carcinoma: A Systematic Review,&#x201d; Journal of Oral Pathology &amp; Medicine 50, no. 8 (2021): 741&#x2013;749, 10.1111/jop.13159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jop.13159</ArticleId><ArticleId IdType="pubmed">33455041</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin F., Ayyildiz V., Gozgec E., Koksal A., Ogul H., and Kantarci M., &#x201c;Multiple Oncocytomas of Bilateral Parotid Glands: A Case Report,&#x201d; Ear, Nose, &amp; Throat Journal 101, no. 9 (2022): NP416&#x2013;NP419, 10.1177/01455613221133227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613221133227</ArticleId><ArticleId IdType="pubmed">36202142</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastrup N., Bretlau P., Krogdahl A., and Melchiors H., &#x201c;Oncocytomas of the Salivary Glands,&#x201d; Acta Oto&#x2010;Laryngologica 96, no. 1&#x2013;2 (1982): 1027&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">7130843</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan J. A., Krolls S. O., Sneed W. F., and Wetzel W. J., &#x201c;Oncocytoma in the Nasal Vestibule,&#x201d; Otolaryngology and Head and Neck Surgery 99, no. 1 (1988): 63&#x2013;65, 10.1177/019459988809900112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/019459988809900112</ArticleId><ArticleId IdType="pubmed">3140185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera R. D. and Nelson B. L., &#x201c;Sine Qua Non: Oncocytoma,&#x201d; Head and Neck Pathology 16, no. 4 (2022): 1167&#x2013;1171, 10.1007/s12105-022-01462-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12105-022-01462-5</ArticleId><ArticleId IdType="pmc">PMC9729656</ArticleId><ArticleId IdType="pubmed">35834095</ArticleId></ArticleIdList></Reference><Reference><Citation>Motallebnejad M., Seyedmajidi M., Khakbaz Baboli O., and Yarmand F., &#x201c;Oncocytoma of Palatal Minor Salivary Gland,&#x201d; Archives of Iranian Medicine 18, no. 5 (2015): 320&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">25959915</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahi S., Bhandari T. R., Thapa P. B., and Shrestha D., &#x201c;Buccal Oncocytoma: Report of a Case and Literature Review,&#x201d; Annals of Medicine and Surgery 43 (2019): 82&#x2013;84, 10.1016/j.amsu.2019.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2019.05.016</ArticleId><ArticleId IdType="pmc">PMC6581872</ArticleId><ArticleId IdType="pubmed">31245002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakthikumar K. R. V., Mohanty S., and Dineshkumar K., &#x201c;Solitary Oncocytoma of the Submandibular Salivary Gland in an Adolescent Female: A Case Report,&#x201d; Indian Journal of Otolaryngology and Head &amp; Neck Surgery 59, no. 2 (2007): 171&#x2013;173, 10.1007/s12070-007-0051-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-007-0051-0</ArticleId><ArticleId IdType="pmc">PMC3451789</ArticleId><ArticleId IdType="pubmed">23120423</ArticleId></ArticleIdList></Reference><Reference><Citation>Stomeo F., Meloni F., Bozzo C., Fois V., and Pastore A., &#x201c;Bilateral Oncocytoma of the Parotid Gland,&#x201d; Acta Oto&#x2010;Laryngologica 126, no. 3 (2006): 324&#x2013;326, 10.1080/00016480500388927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016480500388927</ArticleId><ArticleId IdType="pubmed">16618664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T., Motoori K., Hanazawa T., Nagai Y., and Ito H., &#x201c;MR Imaging of Multinodular Bilateral Oncocytoma of the Parotid Gland,&#x201d; European Journal of Radiology Extra 63, no. 3 (2007): 97&#x2013;100, 10.1016/j.ejrex.2007.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrex.2007.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Colreavy M. P., Sigston E., Lacy P. D., Balasubramaniam G. S., and Lyons B. M., &#x201c;Post&#x2010;Nasal Space Oncocytoma: A Different Approach to a Rare Tumour,&#x201d; Journal of Laryngology and Otology 115, no. 1 (2001): 57&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">11233628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sk&#xe1;lov&#xe1; I., St&#xe1;rek M., Michal I., and Leivo I., &#x201c;Malignancy&#x2010;Simulating Change in Parotid Gland Oncocytoma Following Fine Needle Aspiration: Report of 3 Cases,&#x201d; Pathology, Research and Practice 195, no. 6 (1999): 399&#x2013;405, 10.1016/S0344-0338(99)80013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0344-0338(99)80013-2</ArticleId><ArticleId IdType="pubmed">10399180</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson D., Fu Y. S., and Canalis R. F., &#x201c;Transitional Features of Benign and Malignant Oncocytic Tumors: Report of Two Cases,&#x201d; American Journal of Otolaryngology 17, no. 5 (1996): 335&#x2013;339, 10.1016/S0196-0709(96)90021-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-0709(96)90021-6</ArticleId><ArticleId IdType="pubmed">8870940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziad F., Sinha S., White J., and Pandya H., &#x201c;A Spectrum of Oncocytic Lesions in the Parotid Gland of a Patient With Sarcoidosis,&#x201d; Pathology 44, no. 6 (2012): 574&#x2013;576, 10.1097/PAT.0b013e3283583515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAT.0b013e3283583515</ArticleId><ArticleId IdType="pubmed">22935985</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva L. P., Serpa M. S., Viveiros S. K., et&#xa0;al., &#x201c;Salivary Gland Tumors in a Brazilian Population: A 20&#x2010;Year Retrospective and Multicentric Study of 2292 Cases,&#x201d; Journal of Cranio&#x2010;Maxillo&#x2010;Facial Surgery 46, no. 12 (2018): 2227&#x2013;2233, 10.1016/j.jcms.2018.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcms.2018.09.028</ArticleId><ArticleId IdType="pubmed">30528989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodzic Z., Rowan N. R., Kashiwazaki R., Willson T. J., Wang E. W., and Lee S. E., &#x201c;A Systematic Review of Sinonasal Oncocytomas and Oncocytic Carcinomas: Diagnosis, Management, and Technical Considerations,&#x201d; International Forum of Allergy &amp; Rhinology 7, no. 5 (2017): 514&#x2013;524, 10.1002/alr.21902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21902</ArticleId><ArticleId IdType="pubmed">28092140</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki Y. and Sakaguchi R., &#x201c;Synchronous Oncocytoma and Warthin's Tumor in the Ipsilateral Parotid Gland,&#x201d; Auris Nasus Larynx 31, no. 1 (2004): 73&#x2013;78, 10.1016/j.anl.2003.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anl.2003.07.008</ArticleId><ArticleId IdType="pubmed">15041058</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez F., Vivanco B., Su&#xe1;rez C., and Llorente J. L., &#x201c;Anterior Skull Base Oncocytoma,&#x201d; Journal of Craniofacial Surgery 24, no. 2 (2013): e199&#x2013;e201, 10.1097/SCS.0b013e3182802285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SCS.0b013e3182802285</ArticleId><ArticleId IdType="pubmed">23524838</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrese J. L., Lau S., Chen B. T., and Maghami E., &#x201c;Nonparotid Parapharyngeal Oncocytoma: A Case Report and Literature Review,&#x201d; Head &amp; Neck 32, no. 6 (2010): 800&#x2013;805, 10.1002/hed.21237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.21237</ArticleId><ArticleId IdType="pubmed">19787785</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida K., Miyagawa M., Kido T., et&#xa0;al., &#x201c;Parotid Oncocytoma as a Manifestation of Birt&#x2010;Hogg&#x2010;Dub&#xe9; Syndrome,&#x201d; Case Reports in Radiology 2018 (2018): 1&#x2013;7, 10.1155/2018/6265175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/6265175</ArticleId><ArticleId IdType="pmc">PMC6008813</ArticleId><ArticleId IdType="pubmed">29971177</ArticleId></ArticleIdList></Reference><Reference><Citation>Menko F. H., van Steensel M. A., Giraud S., et&#xa0;al., &#x201c;Birt&#x2013;Hogg&#x2013;Dub&#xe9; Syndrome: Diagnosis and management,&#x201d; Lancet Oncology 10, no. 12 (2009): 1199&#x2013;1206, 10.1016/S1470-2045(09)70188-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(09)70188-3</ArticleId><ArticleId IdType="pubmed">19959076</ArticleId></ArticleIdList></Reference><Reference><Citation>Subha S., Nordin A., Mohtarrudin N., and Saad F., &#x201c;Parotid Oncocytoma in Birt&#x2010;Hogg&#x2010;Dub&#xe9; Syndrome: A New Pitfall in 18F&#x2010;Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging Study,&#x201d; Pertanika Journal of Science &amp; Technology 24, no. 1 (2016): 225&#x2013;230.</Citation></Reference><Reference><Citation>Tan T. J. and Tan T. Y., &#x201c;CT Features of Parotid Gland Oncocytomas: A Study of 10 Cases and Literature Review,&#x201d; American Journal of Neuroradiology 31, no. 8 (2010): 1413&#x2013;1417, 10.3174/ajnr.A2090.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2090</ArticleId><ArticleId IdType="pmc">PMC7966095</ArticleId><ArticleId IdType="pubmed">20395389</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellenberger T. D., Williams M. D., Clayman G. L., and Kumar A. J., &#x201c;Parotid Gland Oncocytosis: CT Findings With Histopathologic Correlation,&#x201d; American Journal of Neuroradiology 29, no. 4 (2008): 734&#x2013;736, 10.3174/ajnr.A0938.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A0938</ArticleId><ArticleId IdType="pmc">PMC7978214</ArticleId><ArticleId IdType="pubmed">18272563</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi D. S., Na D. G., Byun H. S., et&#xa0;al., &#x201c;Salivary Gland Tumors: Evaluation With Two&#x2010;Phase Helical CT,&#x201d; Radiology 214, no. 1 (2000): 231&#x2013;236, 10.1148/radiology.214.1.r00ja05231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.214.1.r00ja05231</ArticleId><ArticleId IdType="pubmed">10644130</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray S. R., Cornog J. L., and Seo I. S., &#x201c;Oncocytic Neoplasms of Salivary Glands: A Report of Fifteen Cases Including Two Malignant Oncocytomas,&#x201d; Cancer 38, no. 3 (1976): 1306&#x2013;1317, 10.1002/1097-0142(197609)38:3&lt;1306::AID-CNCR2820380333&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(197609)38:3&lt;1306::AID-CNCR2820380333&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">953970</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau M. N. and Radden B. G., &#x201c;Intra&#x2010;Oral Benign Solid Oncocytoma,&#x201d; International Journal of Oral and Maxillofacial Surgery 15, no. 4 (1986): 503&#x2013;506, 10.1016/S0300-9785(86)80048-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-9785(86)80048-5</ArticleId><ArticleId IdType="pubmed">3091736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo J. H., Choi S. H., Roh J. L., Nam S. Y., Kim S. Y., and Cho K. J., &#x201c;Oncocytoma and Oncocytic Carcinoma of the Salivary Glands, Single Institute Experience,&#x201d; Korean Journal of Pathology 44, no. 4 (2010): 370&#x2013;375, 10.4132/KoreanJPathol.2010.44.4.370.</Citation><ArticleIdList><ArticleId IdType="doi">10.4132/KoreanJPathol.2010.44.4.370</ArticleId></ArticleIdList></Reference><Reference><Citation>Imran S., Allen A., Shokouh&#x2010;Amiri M., Garzon S., and Saran N., &#x201c;Parotid Oncocytoma: CT and Pathologic Correlation of a Rare Benign Parotid Tumor,&#x201d; Radiology Case Reports 15, no. 1 (2020): 31&#x2013;34, 10.1016/j.radcr.2019.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2019.10.003</ArticleId><ArticleId IdType="pmc">PMC6849430</ArticleId><ArticleId IdType="pubmed">31737142</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer E. L., Gruet M., and Jackson A. S., &#x201c;Oncocytic Cell Adenoma of the Parotid Gland,&#x201d; American Journal of Surgery 91, no. 2 (1956): 272&#x2013;278, 10.1016/0002-9610(56)90421-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(56)90421-4</ArticleId><ArticleId IdType="pubmed">13283214</ArticleId></ArticleIdList></Reference><Reference><Citation>Travis B., Palacios E., and McCarty C. L., &#x201c;An Uncommon Case of Laryngeal Oncocytoma,&#x201d; Ear, Nose, &amp; Throat Journal 90, no. 5 (2011): 208&#x2013;210, 10.1177/014556131109000503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014556131109000503</ArticleId><ArticleId IdType="pubmed">21563086</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza&#x2010;Chavez L., &#x201c;Oxyphilic Granular Cell Adenoma of the Parotid Gland (Oncocytoma): Report of Five Cases and Study of Oxyphilic Granular Cells (Oncocytes) in Normal Parotid Glands,&#x201d; American Journal of Pathology 25, no. 3 (1949): 523&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1942909</ArticleId><ArticleId IdType="pubmed">18127139</ArticleId></ArticleIdList></Reference><Reference><Citation>El Korbi S., Jellali M., Njima K., et&#xa0;al., &#x201c;Parotid Gland Oncocytoma: A Rare Case and Literature Review,&#x201d; Journal of Medical Cases 10, no. 5 (2019): 146&#x2013;149, 10.14740/jmc3288.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jmc3288</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E., Altman D. G., Egger M., Pocock S. J., G&#xf8;tzsche P. C., and Vandenbroucke J. P., &#x201c;The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies,&#x201d; International Journal of Surgery 370 (2007): 1453&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40445931</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1731</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>2</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Archivos de cardiologia de Mexico</Title><ISOAbbreviation>Arch Cardiol Mex</ISOAbbreviation></Journal><ArticleTitle>Arrhythmic mitral valve complex: diagnostic and therapeutic approach.</ArticleTitle><Pagination><StartPage>225</StartPage><EndPage>234</EndPage><MedlinePgn>225-234</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/ACM.24000097</ELocationID><Abstract><AbstractText>El prolapso valvular mitral arr&#xed;tmico es una condici&#xf3;n implicada en casos de muerte s&#xfa;bita cardiaca inexplicable que recientemente ha tomado importancia debido a los m&#xe9;todos diagn&#xf3;sticos actuales. Sin embargo, ya que la presencia de prolapso valvular mitral se ha considerado un hallazgo benigno, sus implicaciones arr&#xed;tmicas han sido subestimadas. La importancia de la presente revisi&#xf3;n es destacar par&#xe1;metros cl&#xed;nicos y de gabinete que permitan identificar individuos con riesgo arr&#xed;tmico mediante una estratificaci&#xf3;n apropiada, para as&#xed; poder aplicar medidas terap&#xe9;uticas oportunas y evitar desenlaces fatales.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trujillo-Flores</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Consulta Externa de Cardiolog&#xed;a, Hospital de Especialidades 5 de Mayo, Instituto de Seguridad y Servicios Sociales de los Trabajadores al Servicio de los Poderes del Estado de Puebla (ISSSTEP), Puebla.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Hospitalizaci&#xf3;n de Cardiolog&#xed;a, Hospital de Especialidades 5 de Mayo, ISSSTEP, Puebla.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Ecocardiograf&#xed;a, Hospital de Especialidades 5 de Mayo, ISSSTEP, Puebla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Aguilera</LastName><ForeName>Fanny de Dios</ForeName><Initials>FD</Initials><AffiliationInfo><Affiliation>Servicio de Hospitalizaci&#xf3;n de Cardiolog&#xed;a, Hospital de Especialidades 5 de Mayo, ISSSTEP, Puebla.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Ru&#xed;z</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Cardiolog&#xed;a, Centro M&#xe9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Ciudad de M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couti&#xf1;o-P&#xe9;rez</LastName><ForeName>&#xc1;lvaro</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Medicina Interna, Hospital General de Zona No. 2, IMSS, Tuxtla Guti&#xe9;rrez, Chiapas. M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Complejo valvular mitral arr&#xed;tmico: abordaje diagn&#xf3;stico y terap&#xe9;utico.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Arch Cardiol Mex</MedlineTA><NlmUniqueID>101126728</NlmUniqueID><ISSNLinking>1665-1731</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008945" MajorTopicYN="Y">Mitral Valve Prolapse</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>The arrhythmic mitral valve prolapse is an entity involved in cases of unexplained sudden cardiac death, which has recently gained importance due to current diagnostic methods. However, since the presence of mitral valve prolapse has been considered a benign finding, its arrhythmic implications have been underestimated. The importance of the present review is to highlight clinical and office parameters that allow identifying individuals with arrhythmic risk through appropriate stratification, in order to apply timely therapeutic measures and avoid fatal outcomes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Permanyer.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmic mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">Disyunci&#xf3;n del anillo mitral</Keyword><Keyword MajorTopicYN="N">Mitral annulus disjunction</Keyword><Keyword MajorTopicYN="N">Mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">Muerte s&#xfa;bita cardiaca</Keyword><Keyword MajorTopicYN="N">Prolapso valvular mitral</Keyword><Keyword MajorTopicYN="N">Prolapso valvular mitral arr&#xed;tmico</Keyword><Keyword MajorTopicYN="N">Sudden cardiac death</Keyword></KeywordList><CoiStatement>Ninguno.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>18</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40445931</ArticleId><ArticleId IdType="pmc">PMC12058091</ArticleId><ArticleId IdType="doi">10.24875/ACM.24000097</ArticleId><ArticleId IdType="pii">j95/2/225</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022;24:1981&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11636573</ArticleId><ArticleId IdType="pubmed">35951656</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqarawi W, Burwash IG, Krahn AD, Healey JS. Arrhythmic mitral valve prolapse:risk assessment and management. Can J Cardiol. 2023;39:1397&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">37217162</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Sabbag A, El-Am E, Cavalcante JL, Michelena HI, Enr&#xed;quez-Sarano M. Arrhythmic mitral valve prolapse and mitral annular disjunction:pathophysiology, risk stratification, and management. Eur Heart J. 2023;44:3121&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">37561995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivulescu M, Aabel E, Dejgaard L, Steen T, Dunlop O, Haugaa KH. Cardiac arrest in a patient with arrhythmic mitral valve prolapse syndrome:multiple possible etiologies. JACC Case Rep. 2021;3:1769&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8603045</ArticleId><ArticleId IdType="pubmed">34825207</ArticleId></ArticleIdList></Reference><Reference><Citation>Faletra FF, Agricola E, Flachskampf FA, Hahn R, Pepi M, Ajmone Marsan N, et al. Three-dimensional transoesophageal echocardiography:how to use and when to use-a clinical consensus statement from the European Association of Cardiovascular Imaging of the European Society of Cardiology. Eur Heart J Cardiovasc Imaging. 2023;24:e119&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">37259019</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoen FJ. Evolving concepts of cardiac valve dynamics:the continuum of development, functional structure, pathobiology and tissue engineering. Circulation. 2008;118:1864&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18955677</ArticleId></ArticleIdList></Reference><Reference><Citation>Silbiger JJ. Anatomy, mechanics, and pathophysiology of the mitral annulus. Am Heart J. 2012;164:163&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">22877801</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbi M, Monaghan MJ. Quantitative mitral valve anatomy and pathology. Echo Res Pract. 2015;2:R63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676476</ArticleId><ArticleId IdType="pubmed">26693344</ArticleId></ArticleIdList></Reference><Reference><Citation>Faletra FF, Leo LA, Paiocchi V, Schlossbauer S, Narula J, Ho SY. Multimodality imaging anatomy of interatrial septum and mitral annulus. Heart. 2020 heartjnl-2020-318127.</Citation><ArticleIdList><ArticleId IdType="pubmed">33443019</ArticleId></ArticleIdList></Reference><Reference><Citation>Faletra FF, Leo LA, Paiocchi VL, Caretta A, Viani GM, Schlossbauer SA, et al. Anatomy of mitral annulus insights from non-invasive imaging techniques. Eur Heart J Cardiovasc Imaging. 2019;20:843&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">31219549</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10387935</ArticleId></ArticleIdList></Reference><Reference><Citation>Delling FN, Rong J, Larson MG, Lehman B, Fuller D, Osypiuk E, et al. Evolution of mitral valve prolapse. Circulation. 2016;133:1688&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856536</ArticleId><ArticleId IdType="pubmed">27006478</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">19356795</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Sabbag A, Antoine C, Benfari G, Yang L, Maalouf J, et al. Presentation and outcome of arrhythmic mitral valve prolapse. J Am Coll Cardiol. 2020;76:637&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">32762897</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalliah CJ, Mahajan R, Elliott AD, Haqqani H, Lau DH, Vohra JK, et al. Mitral valve prolapse and sudden cardiac death:a systematic review and meta-analysis. Heart. 2019;105:144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30242141</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigioni F, Enriquez-Sarano M, Ling L, Bailey K, Seward J, Tajik A, et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol. 1999;34:2078&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10588227</ArticleId></ArticleIdList></Reference><Reference><Citation>Delling FN, Aung S, Vittinghoff E, Dave S, Lim LJ, Olgin JE, et al. Antemortem and post-mortem characteristics of lethal mitral valve prolapse among all countywide sudden deaths. JACC Clin Electrophysiol. 2021;7:1025&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374002</ArticleId><ArticleId IdType="pubmed">33640349</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26160859</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqarawi W, Tadros R, Roberts JD, Cheung CC, Green MS, Burwash IG, et al. The prevalence and characteristics of arrhythmic mitral valve prolapse in patients with unexplained cardiac arrest. JACC Clin Electrophysiol. 2023;9:2494&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">37804262</ArticleId></ArticleIdList></Reference><Reference><Citation>Han HC, Ha FJ, Teh AW, Calafiore P, Jones EF, Johns J, et al. Mitral valve prolapse and sudden cardiac death:a systematic review. J Am Heart Assoc. 2018;7:e010584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405538</ArticleId><ArticleId IdType="pubmed">30486705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation:a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">28314623</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudoulas KD, Pitsis AA, Gumina RJ, Mazzaferri EL, Triposkiadis F, Boudoulas H. Floppy mitral valve/mitral valve prolapse:a complex entity with multiple genotypes and phenotymes. Progr Cardiovasc Dis. 2020;63:308&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">32201287</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoine C, Mantovani F, Benfari G, Mankad SV, Maalouf JF, Michelena HI, et al. Pathophysiology of degenerative mitral regurgitation:new 3-dimensional imaging insights. Circ Cardiovasc Imaging. 2018;11:e005971.</Citation><ArticleIdList><ArticleId IdType="pubmed">29321211</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wijngaarden AL, Kruithof BPT, Vinella T, Barge-Schaapveld DQCM, Ajmone Marsan N. Characterization of degenerative mitral valve disease:Differences between fifibroelasti defificiency and Barlow's disease. J Cardiovasc Dev Dis. 2021;8:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7926852</ArticleId><ArticleId IdType="pubmed">33671724</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudoulas KD, Pitsis A, Triposkiadis F, Han Y, Savona SJ, Stefanadis C, et al. Floppy mitral valve/mitral valve prolapse and sudden cardiac death. Prog Cardiovasc Dis. 2022;74:89&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">36279946</ArticleId></ArticleIdList></Reference><Reference><Citation>Delwarde C, Capoulade R, M&#xe9;rot J, Le Scouarnec S, Bouatia-Naji N, Yu M, et al. Genetics and pathophysiology of mitral valve prolapse. Front Cardiovasc Med. 2023;10:1077788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978496</ArticleId><ArticleId IdType="pubmed">36873395</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudicessi JR, Maleszewski JJ, Tester DJ, Ackerman MJ. Prevalence and potential genetic determinants of young sudden unexplained death victims with suspected arrhythmogenic mitral valve prolapse syndrome. Heart Rhythm O2. 2021;2:431&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505213</ArticleId><ArticleId IdType="pubmed">34667957</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Mantovani F, Benfari G, Maalouf JF, Mankad S, Thapa P, et al. Mitral annular disjunction of degenerative mitral regurgitation:three-dimensional evaluation and implications for mitral repair. J Am Soc Echocardiogr. 2022;35:165&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">34517112</ArticleId></ArticleIdList></Reference><Reference><Citation>Pype LL, Bertrand PB, Paelinck BP, Heidbuchel H, Van Craenenbroeck EM, Van De Heyning CM. Left ventricular remodeling in non-syndromic mitral valve prolapse:volume overload or concomitant cardiomyopathy? Front Cardiovasc Med. 2022;9:862044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9039519</ArticleId><ArticleId IdType="pubmed">35498019</ArticleId></ArticleIdList></Reference><Reference><Citation>Konda T, Tani T, Suganuma N, Nakamura H, Sumida T, Fujii Y, et al. The analysis of mitral annular disjunction detected by echocardiography and comparison with previously reported pathological data. J Echocardiogr. 2017;15:176&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">28799132</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Tafuro J, Duckett S, Appaji A, Khan JN, Heatlie G, et al. Definition, prevalence, and clinical significance of mitral annular disjunction in different patient cohorts:a systematic review. Echocardiography. 2022;39:514&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">35122307</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh H, Mori S, Izawa Y, Fujita H, Miwa K, Suzuki M, et al. Prevalence and extent of mitral annular disjunction in structurally normal hearts:comprehensive 3D analysis using cardiac computed tomography. Eur Heart J Cardiovasc Imaging. 2021;22:614&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">33713105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Zhao Q, Zeng X, Zheng D, Yue J, Zhang K, et al. Association of mitral annular disjunction with premature cardiac mortality in a large series of autopsies. J Am Coll Cardiol. 2021;77:102&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">33413931</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantegazza V, Tamborini G, Muratori M, Gripari P, Fusini L, Italiano G, et al. Mitral annular disjunction in a large cohort of patients with mitral valve prolapse and significant regurgitation. JACC Cardiovasc Imaging. 2019;12:2278&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">31422124</ArticleId></ArticleIdList></Reference><Reference><Citation>Putnam AJ, Kebed K, Mor-Avi V, Rashedi N, Sun D, Patel B, et al. Prevalence of mitral annular disjunction in patients with mitral valve prolapse and severe regurgitation. Int J Cardiovasc Imaging. 2020;36:1363&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178815</ArticleId><ArticleId IdType="pubmed">32221771</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejgaard LA, Skjolsvik ET, Lie OH, Ribe M, Stokke MK, Hegbom F, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72:1600&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30261961</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson MJ, Bitkover CY, Omran AS, David TE, Ivanov J, Ali MJ, et al. Mitral annular disjunction in advanced myxomatous mitral valve disease:echocardiographic detection and surgical correction. J Am Soc Echocardiogr. 2005;18:1014&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198877</ArticleId></ArticleIdList></Reference><Reference><Citation>Konda T, Tani T, Furukawa Y. Mitral annular disjunction in consecutive cases:echocardiographic detection. J Am Coll Cardiol. 2013;61:E1046.</Citation></Reference><Reference><Citation>Drescher CS, Kelsey MD, Yankey GS, Sun AY, Wang A, Sadeghpour A, et al. Imaging considerations and clinical implications of mitral annular disjunction. Circ Cardiovasc Imaging. 2022;15:e014243.</Citation><ArticleIdList><ArticleId IdType="pubmed">36126123</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveri F, Kakargias F, Panday P, Arcia Franchini AP, Iskander B, Anwer F, et al. Arrhythmic mitral valve prolapse:diagnostic parameters for high-risk patients:a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021;44:1746&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">34397120</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Iliceto S, Thiene G, Perazzolo Marra M. Mitral valve prolapse, ventricular arrhythmias, and sudden death. Circulation. 2019;140:952&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31498700</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee NA, Singh JP. Autonomic modulation and cardiac arrhythmias:old insights and novel strategies. Europace. 2021;23:1708&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">34050642</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura-Ferreira S, Vandenberk B, Masci PG, Dresselaers T, Garweg C, Symons R, et al. Left ventricular remodeling in mitral valve prolapse patients:implications of apical papillary muscle insertion. Eur Heart J Cardiovasc Imaging. 2021;22:1119&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">34279022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bumgarner JM, Patel D, Kumar A, Clevenger JR, Trulock KM, Popovic Z, et al. Management and outcomes in mitral valve prolapse with ventricular arrhythmias undergoing ablation and/or implantation of ICDs. Pacing Clin Electrophysiol. 2019;42:447&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">30680747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesler E, King RA, Edwards JE. The myxomatous mitral valve and sudden death. Circulation. 1983;67:632&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">6821906</ArticleId></ArticleIdList></Reference><Reference><Citation>Appignani M, Khanji MY, Arbustini E, Stuppia L, Ceriello L, Girolamo ED, et al. Is occult genetic substrate the missing link between arrhythmic mitral annular disjunction syndrome and sudden cardiac death? Can J Cardiol. 2021;37:1651&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">33933609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bains S, Tester D, Asirvatham S, Noseworthy P, Ackerman M, Giudicessi J. A novel truncating variant in FLNC-encoded filamin C may serve as a proarrhythmic genetic substrate for arrhythmogenic bileaflet mitral valve prolapse syndrome. Mayo Clin Proc. 2019;94:906&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">30935706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. N Engl J Med. 1986;314:535&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">3945291</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbi M, Lancellotti P, Sheppard MN. Mitral valve and left ventricular features in malignant mitral valve prolapse. Open Heart. 2018;5:e000925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196952</ArticleId><ArticleId IdType="pubmed">30364469</ArticleId></ArticleIdList></Reference><Reference><Citation>Han HC, Parsons SA, Teh AW, Sanders P, Neil C, Leong T, et al. Characteristic histopathological findings and cardiac arrest rhythm in isolated mitral valve prolapse and sudden cardiac death. J Am Heart Assoc. 2020;9:e015587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428599</ArticleId><ArticleId IdType="pubmed">32233752</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez B, Ravassa S, Moreno MU, Jos&#xe9; GS, Beaumont J, Gonz&#xe1;lez A, et al. Diffuse myocardial fibrosis:mechanisms, diagnosis and therapeutic approaches. Nat Rev Cardiol. 2021;18:479&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33568808</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med. 1999;341:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10387935</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjanuwattra J, Kewcharoen J, Phinyo P, Swusdinaruenart S, Abdelnabi M, Del Rio-Pertuz G, et al. High-risk phenotypes of arrhythmic mitral valve prolapse:a systematic review and meta-analysis. Acta Cardiol. 2023;78:1012&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">37358248</ArticleId></ArticleIdList></Reference><Reference><Citation>Five CK, Hasselberg NE, Aaserud LT, Castrini AI, Vlaisavljevic K, Lie &#xd8;, et al. Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse. Europace. 2023;25:euad309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10616587</ArticleId><ArticleId IdType="pubmed">37851515</ArticleId></ArticleIdList></Reference><Reference><Citation>Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease:Barlow's disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg. 2007;19:90&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17870001</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheirlynck E, Dejgaard LA, Skj&#xf8;lsvik E, Lie OH, Motoc A, Hopp E, et al. Increased levels of sST2 in patients with mitral annulus disjunction and ventricular arrhythmias. Open Heart. 2019;6:e001016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519435</ArticleId><ArticleId IdType="pubmed">31168386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya &#xdc;, Eren H. Fragmented QRS may be associated with complex ventricular arrhythmias in mitral valve prolapse. Minerva Cardioangiol. 2020;68:577&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32138502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bazoukis G, Saplaouras A, Vlachos K, Mililis P, Letsas KP, Efremidis M, et al. Predictors of ventricular arrhythmias in patients with mitral valve prolapse:a meta-analysis. Cardiol Rev. 2023 Jun 19; doi:10.1097/CRD.0000000000000577. Online ahead of print.</Citation><ArticleIdList><ArticleId IdType="pubmed">37335822</ArticleId></ArticleIdList></Reference><Reference><Citation>Akcay M, Yuce M, Pala S, Akcakoyun M, Ergelen M, Kargin R, et al. Anterior mitral valve length is associated with ventricular tachycardia in patients with classical mitral valve prolapse:predictors of ventricular tachycardia in mitral valve prolapse. Pacing Clin Electrophysiol. 2010;33:1224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">20546149</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouridakis EG, Parthenakis FI, Kochiadakis GE, Kanoupakis EM, Vardas PE. QT dispersion in patients with mitral valve prolapse is related to the echocardiographic degree of the prolapse and mitral leaflet thickness. Europace. 2001;3:292&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11678387</ArticleId></ArticleIdList></Reference><Reference><Citation>Raja DC, Rangaswamy VV, Abhilash SP, King K, Pathak RK. Electrophysiological substrates in papillary muscle arrhythmias &#x2013;implications for catheter ablation. European Journal of Arrhythmia &amp;Electrophysiology. 2020;6:32.</Citation></Reference><Reference><Citation>Giudicessi JR, Rohatgi RK, Bos JM, Ackerman MJ. Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse. Int J Cardiol. 2019;274:175&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30219255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison GH, Abreau S, Barrios J, Lim LJ, Yang M, Crudo V, et al. Identifying mitral valve prolapse at risk for arrhythmias and fibrosis from electrocardiograms using deep learning. JACC Adv. 2023;2:100446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10629907</ArticleId><ArticleId IdType="pubmed">37936601</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino PG, Madeo A, Luc&#xe0; F, Ceravolo R, di Fusco SA, Benedetto FA, et al. Clinical utility of three-dimensional echocardiography in the evaluation of mitral valve disease:tips and tricks. J Clin Med. 2023;2522;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10094963</ArticleId><ArticleId IdType="pubmed">37048605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamborini G, Mantegazza V, Garlasche A, Muratori M, Fusini L, Ghulam Ali S, et al. Head to head comparison between different 3-dimensional echocardiographic rendering tools in the imaging of percutaneous edge-to-edge mitral valve repair. J Cardiovasc Dev Dis. 2021;8:156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8304678</ArticleId><ArticleId IdType="pubmed">34202460</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DH, Rosenhek R, Falk V. Degenerative mitral valve regurgitation:best practice revolution. Eur Heart J. 2010;31:1958&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2921508</ArticleId><ArticleId IdType="pubmed">20624767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pistelli L, Vetta G, Parlavecchio A, Crea P, Parisi F, Magnocavallo M, et al. Arrhythmic risk profile in mitral valve prolapse:a systematic review and metanalysis of 1715 patients. J Cardiovasc Electrophysiol. 2024;35:290&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">38098308</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld SA, Kirkels FP, Cramer MJ, Evertz R, Haugaa KH, Postema PG, et al. Prevalence of mitral annulus disjunction and mitral valve prolapse in patients with idiopathic ventricular fibrillation. J Am Heart Assoc. 2022;11:e025364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9496286</ArticleId><ArticleId IdType="pubmed">35929463</ArticleId></ArticleIdList></Reference><Reference><Citation>Vairo A, Desalvo P, Rinaudo A, Piroli F, Tribuzio A, Ballatore A, et al. Echocardiographic parameters to predict malignant events in arrhythmic mitral valve prolapse population. J Clin Med. 2023;1232;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917801</ArticleId><ArticleId IdType="pubmed">36769881</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantegazza V, Volpato V, Gripari P, Ghulam Ali S, Fusini L, Italiano G, et al. Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse. Heart. 2021;107:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">32723759</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza AC, Carvalho MVSF, Sales MA, Bezerra SL, Torre&#xe3;o JA, Mac&#xea;do CT. Mitral annulus disjunction:diagnostic modalities, clinical implications, and prognostic progression. Arq Bras Cardiol Imagem Cardiovasc. 2022;35:eabc300.</Citation></Reference><Reference><Citation>Lee AP, Jin CN, Fan Y, Wong RHL, Underwood MJ, Wan S. Functional implication of mitral annular disjunction in mitral valve prolapse:a quantitative dynamic 3D echocardiographic study. JACC Cardiovasc Imaging. 2017;10:1424&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528161</ArticleId></ArticleIdList></Reference><Reference><Citation>Essayagh B, Sabbag A, Antoine C, Benfari G, Batista R, Yang LT, et al. The mitral annular disjunction of mitral valve prolapse:presentation and outcome. JACC Cardiovasc Imaging. 2021;14:2073&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">34147457</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavich M, Palmisano A, Pannone L, Agricola E, Margonato A, Esposito A. Hidden danger behind the prolapse. Circ Cardiovasc Imaging. 2019;12:e009639.</Citation><ArticleIdList><ArticleId IdType="pubmed">31569957</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. Mitral annular disjunction in myxomatous mitral valve disease:a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound. 2010;8:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014886</ArticleId><ArticleId IdType="pubmed">21143934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TKM, Kwon DH, Abou-Hassan O, Chetrit M, Harb SC, Patel D, et al. Strain evaluation for mitral annular disjunction by echocardiography and magnetic resonance imaging:a case-control study. Int J Cardiol. 2021;334:154&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33932426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace N, Sellal JM, Venner C, Mandry D, Marie PY, Filippetti L, et al. Myocardial deformation in malignant mitral valve prolapse:a shifting paradigm to dynamic mitral valve-ventricular interactions. Front Cardiovasc Med. 2023;10:1140216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10130669</ArticleId><ArticleId IdType="pubmed">37123476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermakov S, Gulhar R, Lim L, Bibby D, Fang Q, Nah G, et al. Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse. Heart. 2019;105:1063&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658737</ArticleId><ArticleId IdType="pubmed">30755467</ArticleId></ArticleIdList></Reference><Reference><Citation>Brainin P, Biering-Sorensen SR, Mogelvang R, Sogaard P, Jensen JS, Biering-Sorensen T. Postsystolic shortening by speckle tracking echocardiography is an independent predictor of cardiovascular events and mortality in the general population. J Am Heart Assoc. 2018;7:e008367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5907576</ArticleId><ArticleId IdType="pubmed">29519813</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukumar L, Rahman F, Jan MF, Shaikh A, Kalvin L, Dhala A, et al. The pickelhaube sign:novel echocardiographic risk marker for malignant mitral valve prolapse syndrome. JACC Cardiovasc Imaging. 2017;10:1078&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">28017396</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani&#x142;owicz-Szymanowicz L, Zienciuk-Krajka A, Wabich E, Fija&#x142;kowski M, Fija&#x142;kowska J, M&#x142;odzi&#x144;ski K, et al. Left ventricle segmental longitudinal strain and regional myocardial work index could help determine mitral valve prolapse patients with increased risk of ventricular arrhythmias. J Cardiovasc Dev Dis. 2023;10:181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145267</ArticleId><ArticleId IdType="pubmed">37103060</ArticleId></ArticleIdList></Reference><Reference><Citation>Spampinato RA, Lindemann F, Jahnke C, Paetsch I, Fahr F, Sieg F, et al. Quantification of regurgitation in mitral valve prolapse with automated real time echocardiographic 3D proximal isovelocity surface area:multimodality consistency and role of eccentricity index. Int J Cardiovasc Imaging. 2021;37:1947&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255267</ArticleId><ArticleId IdType="pubmed">33616785</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, et al. Mitral valve prolapse in the general population:the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. 2002;40:1298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">12383578</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyten P, Heuts S, Cheriex E, Olsthoorn JR, Crijns HJGM, Winkens B, et al. Mitral prolapsing volume is associated with increased cardiac dimensions in patients with mitral annular disjunction. Neth Heart J. 2021;30:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8881558</ArticleId><ArticleId IdType="pubmed">33945108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirasawa K, Izumo M, Umemoto T, Suzuki K, Kitanaka Y, Oi K, et al. Geometry of tricuspid valve apparatus in patients with mitral regurgitation due to fibroelastic deficiency versus Barlow disease:a real-time three-dimensional transesophageal echocardiography study. J Am Soc Echocardiogr. 2020;33:1095&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">32561111</ArticleId></ArticleIdList></Reference><Reference><Citation>Musella F, Azzu A, Antonopoulos AS, La Mura L, Mohiaddin RH. Comprehensive mitral valve prolapse assessment by cardiovascular MRI. Clin Radiol. 2022;77:e120&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34895911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R, et al. Multi-modality imaging assessment of native valvular regurgitation:an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging. 2022;23:e171&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">35292799</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008;1:294&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">19356441</ArticleId></ArticleIdList></Reference><Reference><Citation>Faletra FF, Leo LA, Paiocchi VL, Schlossbauer SA, Pavon AG, Ho SY, et al. Morphology of mitral annular disjunction in mitral valve prolapse. J Am Soc Echocardiogr. 2022;35:176&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">34508838</ArticleId></ArticleIdList></Reference><Reference><Citation>Aabel EW, Chivulescu M, Dejgaard LA, Ribe M, Gjertsen E, Hopp E, et al. Tricuspid annulus disjunction:novel findings by cardiac magnetic resonance in patients with mitral annulus disjunction. JACC Cardiovasc Imaging. 2021;14:1535&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">33744128</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia MI, Valenti V, Cherston C, Criscito M, Uretsky S, Wolff S. Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging. Am J Cardiol. 2012;109:1321&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22335854</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata Y, Bertrand PB, Baliyan V, Kochav J, Kagan RD, Ujka K, et al. Abnormal mechanics relate to myocardial fibrosis and ventricular arrhythmias in patients with mitral valve prolapse. Circ Cardiovasc Imaging. 2023;16:e014963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10108844</ArticleId><ArticleId IdType="pubmed">37071717</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant Dit Beaufils AL, Huttin O, Jobbe-Duval A, Senage T, Filippetti L, Piriou N, et al. Replacement myocardial fibrosis in patients with mitral valve prolapse:relation to mitral regurgitation, ventricular remodeling, and arrhythmia. Circulation. 2021;143:1763&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">33706538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitkungvan D, Nabi F, Kim RJ, Bonow RO, Khan MA, Xu J, et al. Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol. 2018;72:823&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">30115220</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglielmo M, Arangalage D, Bonino MA, Angelini G, Bonanni M, Pontone G, et al. Additional value of cardiac magnetic resonance feature tracking parameters for the evaluation of the arrhythmic risk in patients with mitral valve prolapse. J Cardiovasc Magn Reson. 2023;25:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10268415</ArticleId><ArticleId IdType="pubmed">37316826</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglielmo M, Fusini L, Muscogiuri G, Baessato F, Loffreno A, Cavaliere A, et al. T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse. Eur Radiol. 2020;31:1100&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32803414</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui AH, Roujol S, Foppa M, Kissinger KV, Goddu B, Hauser TH, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart. 2017;103:204&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237392</ArticleId><ArticleId IdType="pubmed">27515954</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavon AG, Arangalage D, Pascale P, Hugelshofer S, Rutz T, Porretta AP, et al. Myocardial extracellular volume by T1 mapping:a new marker of arrhythmia in mitral valve prolapse. J Cardiovasc Magn Reson. 2021;23:102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438990</ArticleId><ArticleId IdType="pubmed">34517908</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards NC, Moody WE, Yuan M, Weale P, Neal D, Townend JN, et al. Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging. 2014;7:946&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">25140067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitkungvan D, Yang EY, El Tallawi KC, Nagueh SF, Nabi F, Khan MA, et al. Extracellular volume in primary mitral regurgitation. JACC Cardiovasc Imaging. 2020;14:1146&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">33341409</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyten P, Heuts S, Cheriex E, Olsthoorn JR, Crijns HJGM, Winkens B, et al. Mitral prolapsing volume is associated with increased cardiac dimensions in patients with mitral annular disjunction. Neth Heart J. 2022;30:131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8881558</ArticleId><ArticleId IdType="pubmed">33945108</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh N, Al-Shehri H, Chan K, Mesana T, Chan V, Chen L, et al. Characterization of mitral valve prolapse with cardiac computed tomography:comparison to echocardiographic and intraoperative findings. Int J Cardiovasc Imaging. 2012;28:855&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21604082</ArticleId></ArticleIdList></Reference><Reference><Citation>Refaat MM, Gharios C, Moorthy MV, Abdulhai F, Blumenthal RS, Jaffa MA, et al. Exercise-induced ventricular ectopy and cardiovascular mortality in asymptomatic individuals. J Am Coll Cardiol. 2021;78:2267&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720278</ArticleId><ArticleId IdType="pubmed">34857087</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MA, Adams DH, Pandis D, Robson PM, Pawale A, Pyzik R, et al. Hybrid positron emission tomography/magnetic resonance imaging in arrhythmic mitral valve prolapse. JAMA Cardiol. 2020;5:1000&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254450</ArticleId><ArticleId IdType="pubmed">32936270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997&#x2013;4126.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017572</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo R, Maan A, Apostolidou E, Khorasani-Zadeh A, Byrnes S, Chebaya P, et al. Identification of a high-risk subgroup with malignant mitral valve prolapse who are predisposed to sudden cardiac death:a review. Crit Pathw Cardiol. 2021;20:31&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32947378</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnar DO, Mairesse GH, Boriani G, Calkins H, Chin A, Coats A, et al. Management of asymptomatic arrhythmias:a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS) Europace. 2019;21:844&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">30882141</ArticleId></ArticleIdList></Reference><Reference><Citation>Aabel EW, Dejgaard LA, Chivulescu M, Helle-Valle TM, Edvardsen T, Hasselberg NE, et al. Flecainide in patients with arrhythmic mitral valve syndrome:a case series. Heart Rhythm. 2023;20:635&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">36566890</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">35363499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JXC, Fong J, Lim HS, Teh AW, Han HC. Ventricular fibrillation episodes related to managed ventricular pacing algorithm in a patient with mitral valve prolapse &#x2014;&#x201c;Arrhythmic MVP due to MVP&#x201d;. J Electrocardiol. 2023;79:58&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">36948089</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera S, Tomas L, Ricapito MP, Nicolas V, Reinoso M, Caro M, et al. Updated results on catheter ablation of ventricular arrhythmias arising from the papillary muscles of the left ventricle. J Arrhythm. 2019;35:99&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373649</ArticleId><ArticleId IdType="pubmed">30805050</ArticleId></ArticleIdList></Reference><Reference><Citation>Enriquez A, Shirai Y, Huang J, Liang J, Briceno D, Hayashi T, et al. Papillary muscle ventricular arrhythmias in patients with arrhythmic mitral valve prolapse:electrophysiologic substrate and catheter ablation outcomes. J Cardiovasc Electrophysiol. 2019;30:827&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">30843306</ArticleId></ArticleIdList></Reference><Reference><Citation>Latchamsetty R, Yokokawa M, Morady F, Kim HM, Mathew S, Tilz R, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol. 2015;1:116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">29759353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzeddine FM, Siontis KC, Giudicessi J, Ackerman MJ, Killu AM, Deshmukh AJ, et al. Substrate characterization and outcomes of catheter ablation of ventricular arrhythmias in patients with mitral annular disjunction. Circ Arrhythm Electrophysiol. 2022;15:e011088.</Citation><ArticleIdList><ArticleId IdType="pubmed">36074649</ArticleId></ArticleIdList></Reference><Reference><Citation>Wo HT, Liao FC, Chang PC, Chou CC, Wen MS, Wang CC, et al. Circumferential ablation at the base of the left ventricular papillary muscles:a highly effective approach for ventricular arrhythmias originating from the papillary muscles. Int J Cardiol. 2016;220:876&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">27400187</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbull S, Kumar S, Campbell T. Surgical cryoablation of malignant papillary muscle arrhythmias during mitral valve prolapse surgery &#x2014;putting a freeze on sudden cardiac death. Heart Lung Circ. 2022;31:1318&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">36162874</ArticleId></ArticleIdList></Reference><Reference><Citation>Marano PJ, Lim LJ, Sanchez JM, Alvi R, Nah G, Badhwar N, et al. Long-term outcomes of ablation for ventricular arrhythmias in mitral valve prolapse. J Interv Card Electrophysiol. 2021;61:145&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769127</ArticleId><ArticleId IdType="pubmed">32506159</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1; MP, Cavalcanti LRP, Van den Eynde J, Amabile A, Escorel Neto AC, Perazzo AM, et al. Respect versus resect approaches for mitral valve repair:a study-level meta-analysis. Trends Cardiovasc Med. 2023;33:225&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">35051591</ArticleId></ArticleIdList></Reference><Reference><Citation>Biaggi P, Jedrzkiewicz S, Gruner C, Meineri M, Karski J, Vegas A, et al. Quantification of mitral valve anatomy by three-dimensional transesophageal echocardiography in mitral valve prolapse predicts surgical anatomy and the complexity of mitral valve repair. J Am Soc Echocardiogr. 2012;25:758&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22537396</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamborini G, Mantegazza V, Penso M, Muratori M, Fusini L, Ali SG, et al. Predictive value of pre-operative 2D and 3D transthoracic echocardiography in patients undergoing mitral valve repair:long term follow up of mitral valve regurgitation recurrence and heart chamber remodeling. J Cardiovasc Dev Dis. 2020;7:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712008</ArticleId><ArticleId IdType="pubmed">33092178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledwoch J, Nommensen A, Keelani A, Meyer-Saraei R, Stiermaier T, Saad M, et al. Impact of transcatheter mitral valve repair on ventricular arrhythmias. Europace. 2019;21:1385&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">31505617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia A, Sharma S, Gati S, B&#xe4;ck M, B&#xf6;rjesson M, Caselli S, et al. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Rev Esp Cardiol (Engl Ed) 2021;74:545.</Citation><ArticleIdList><ArticleId IdType="pubmed">34020769</ArticleId></ArticleIdList></Reference><Reference><Citation>Delise P, Mos L, Sciarra L, Basso C, Biffi A, Cecchi F, et al. Italian Cardiological Guidelines (COCIS) for competitive sport eligibility in athletes with heart disease:update 2020. J Cardiovasc Med (Hagerstown) 2021;22:874&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">33882535</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidbuchel H, Arbelo E, D'Ascenzi F, Borjesson M, Boveda S, Castelletti S, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2:ventricular arrhythmias, channelopathies, and implantable defibrillators. Europace. 2021;23:147&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32596731</ArticleId></ArticleIdList></Reference><Reference><Citation>Five CK, Hasselberg NE, Aaserud LT, Castrini AI, Vlaisavljevic K, Lie &#xd8;, et al. Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse. Europace. 2023;25:euad309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10616587</ArticleId><ArticleId IdType="pubmed">37851515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40197947</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>The Complex Puzzle of Hypertrophic Phenotype: A Practical Approach for the Clinician.</ArticleTitle><Pagination><StartPage>e20240529</StartPage><MedlinePgn>e20240529</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20240529</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20240529</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2025000100401</ELocationID><Abstract><AbstractText>Left ventricular hypertrophy (LVH) represents a frequent observation in clinical practice. Nonetheless, the hypertrophic phenotype emerges as a common manifestation of diverse conditions, thereby presenting a diagnostic conundrum for clinicians. Differentiation among the etiologies of LVH is imperative for therapy decision-making, as different approaches must be implemented for distinct conditions, such as LVH secondary to loading changes, hypertrophic cardiomyopathy (HCM), or HCM mimics. In some instances, an erroneous or late diagnosis may lead to a progression of the underlying disease with worsening functional capacity, high morbidity and mortality. The rational use of cardiovascular multimodality imaging is of great importance when carried out in addition to a thorough clinical assessment and correlated with electrocardiographic findings, providing clues to fill the gaps, being, most of the time, the missing piece to solve this challenging puzzle. An integrative approach is of paramount importance for the evaluation of these patients, as they are often followed by several specialties, with varied systemic manifestations. Although a multidisciplinary team is needed for an optimized follow-up of these patients, the most important player in this journey is the clinician, whose mission is to bring together all the red flags and coordinate all the data for an assertive diagnosis. The objective of this review is to provide a pragmatic methodology, highlighting important clues for discriminating among the diverse conditions that result in LVH.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Felix</LastName><ForeName>Alex Dos Santos</ForeName><Initials>ADS</Initials><Identifier Source="ORCID">0000-0001-7046-8707</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Cardiologia, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DASA - Diagn&#xf3;sticos da Am&#xe9;rica SA, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Complexo Hospitalar Am&#xe9;ricas - Vit&#xf3;ria / Samaritano Barra, Rio de Janeiro, RJ - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barberato</LastName><ForeName>Silvio Henrique</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-0711-7995</Identifier><AffiliationInfo><Affiliation>CardioEco Centro de Diagn&#xf3;stico Cardiovascular, Curitiba, PR - Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Quanta Diagn&#xf3;stico - Ecocardiografia, Curitiba, PR - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>Marcelo Dantas Tavares de</ForeName><Initials>MDT</Initials><Identifier Source="ORCID">0000-0001-8809-8783</Identifier><AffiliationInfo><Affiliation>Universidade Federal da Para&#xed;ba, Jo&#xe3;o Pessoa, PB - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>S&#xed;lvia Aguiar</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-8812-2330</Identifier><AffiliationInfo><Affiliation>Hospital of Santa Marta, Lisboa - Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NOVA Medical School, Lisboa - Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardim</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3812-4872</Identifier><AffiliationInfo><Affiliation>NOVA Medical School, Lisboa - Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital CUF Descobertas, Lisboa - Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>O Complexo Quebra-Cabe&#xe7;a do Fen&#xf3;tipo Hipertr&#xf3;fico: Uma Abordagem Pr&#xe1;tica para o Cl&#xed;nico.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017379" MajorTopicYN="Y">Hypertrophy, Left Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText>A hipertrofia ventricular esquerda (HVE) &#xe9; frequentemente observada na pr&#xe1;tica cl&#xed;nica. No entanto, o fen&#xf3;tipo hipertr&#xf3;fico &#xe9; uma manifesta&#xe7;&#xe3;o comum de diversas condi&#xe7;&#xf5;es, representando, portanto, um enigma para os m&#xe9;dicos em termos de diagn&#xf3;stico. Diferenciar as etiologias da HVE &#xe9; fundamental para a tomada de decis&#xe3;o terap&#xea;utica, pois diferentes abordagens devem ser implementadas para condi&#xe7;&#xf5;es distintas, como HVE secund&#xe1;ria a altera&#xe7;&#xf5;es de carga, cardiomiopatia hipertr&#xf3;fica (CMH) ou mimetizadores de CMH. Em alguns casos, um diagn&#xf3;stico incorreto ou tardio pode levar &#xe0; progress&#xe3;o da doen&#xe7;a de base com perda adicional da capacidade funcional, alta morbidade e mortalidade. O uso racional da multimodalidade de imagem cardiovascular &#xe9; de extrema import&#xe2;ncia quando s&#xe3;o realizados em conjunto com uma avalia&#xe7;&#xe3;o cl&#xed;nica completa e correlacionados com os achados eletrocardiogr&#xe1;ficos, fornecendo pistas para preencher lacunas. Na maioria das vezes, os exames de imagem s&#xe3;o a pe&#xe7;a que falta para resolver esse quebra-cabe&#xe7;a desafiador. Uma abordagem integral &#xe9; de suma import&#xe2;ncia na avalia&#xe7;&#xe3;o desses pacientes, pois, muitas vezes, s&#xe3;o acompanhados por diversas especialidades, com manifesta&#xe7;&#xf5;es sist&#xea;micas variadas. Embora seja necess&#xe1;ria uma equipe multidisciplinar para um acompanhamento otimizado desses pacientes, o agente mais importante nessa jornada &#xe9; o cl&#xed;nico, cuja miss&#xe3;o &#xe9; reunir todos os sinais de alerta e coordenar todos os dados para um diagn&#xf3;stico assertivo. O objetivo desta revis&#xe3;o &#xe9; fornecer uma metodologia pragm&#xe1;tica, destacando pistas importantes para discriminar as diversas condi&#xe7;&#xf5;es que resultam em HVE.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="eng"><AbstractText>Left ventricular hypertrophy (LVH) represents a frequent observation in clinical practice. Nonetheless, the hypertrophic phenotype emerges as a common manifestation of diverse conditions, thereby presenting a diagnostic conundrum for clinicians. Differentiation among the etiologies of LVH is imperative for therapy decision-making, as different approaches must be implemented for distinct conditions, such as LVH secondary to loading changes, hypertrophic cardiomyopathy (HCM), or HCM mimics. In some instances, an erroneous or late diagnosis may lead to a progression of the underlying disease with worsening functional capacity, high morbidity and mortality. The rational use of cardiovascular multimodality imaging is of great importance when carried out in addition to a thorough clinical assessment and correlated with electrocardiographic findings, providing clues to fill the gaps, being, most of the time, the missing piece to solve this challenging puzzle. An integrative approach is of paramount importance for the evaluation of these patients, as they are often followed by several specialties, with varied systemic manifestations. Although a multidisciplinary team is needed for an optimized follow-up of these patients, the most important player in this journey is the clinician, whose mission is to bring together all the red flags and coordinate all the data for an assertive diagnosis. The objective of this review is to provide a pragmatic methodology, highlighting important clues for discriminating among the diverse conditions that result in LVH.</AbstractText></OtherAbstract><CoiStatement><b>Potencial conflito de interesse:</b> N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>8</Day><Hour>13</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>8</Day><Hour>13</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>8</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40197947</ArticleId><ArticleId IdType="pmc">PMC12013738</ArticleId><ArticleId IdType="doi">10.36660/abc.20240529</ArticleId><ArticleId IdType="pii">S0066-782X2025000100401</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D'Andrea A, et al. Role of Multimodality Cardiac Imaging in the Management of Patients with Hypertrophic Cardiomyopathy: An Expert Consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging. 2015;16(3):280. doi: 10.1093/ehjci/jeu291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu291</ArticleId><ArticleId IdType="pubmed">25650407</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology. Eur Heart J. 2014;35(39):2733&#x2013;2779. doi: 10.1093/eurheartj/ehu284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu284</ArticleId><ArticleId IdType="pubmed">25173338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239&#x2013;e1311. doi: 10.1161/CIR.0000000000001250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001250</ArticleId><ArticleId IdType="pubmed">38718139</ArticleId></ArticleIdList></Reference><Reference><Citation>Limongelli G, Monda E, Tramonte S, Gragnano F, Masarone D, Frisso G, et al. Prevalence and Clinical Significance of Red Flags in Patients with Hypertrophic Cardiomyopathy. Int J Cardiol. 2020;299:186&#x2013;191. doi: 10.1016/j.ijcard.2019.06.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.06.073</ArticleId><ArticleId IdType="pubmed">31303393</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Heli&#xf6; T, et al. Diagnostic Work-Up in Cardiomyopathies: Bridging the Gap between Clinical Phenotypes and Final Diagnosis. A Position Statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(19):1448&#x2013;1458. doi: 10.1093/eurheartj/ehs397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs397</ArticleId><ArticleId IdType="pubmed">23211230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, et al. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77(7):922&#x2013;936. doi: 10.1016/j.jacc.2020.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.12.024</ArticleId><ArticleId IdType="pubmed">33602475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement from the American Heart Association. Circulation. 2020;142(1):e7&#x2013;e22. doi: 10.1161/CIR.0000000000000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000792</ArticleId><ArticleId IdType="pubmed">32476490</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the Management of Cardiomyopathies. Eur Heart J. 2023;44(37):3503&#x2013;3626. doi: 10.1093/eurheartj/ehad194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad194</ArticleId><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet ME, Mestroni L, Taylor MRG. Genetic Infiltrative Cardiomyopathies. Heart Fail Clin. 2018;14(2):215&#x2013;224. doi: 10.1016/j.hfc.2017.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hfc.2017.12.003</ArticleId><ArticleId IdType="pmc">PMC5894511</ArticleId><ArticleId IdType="pubmed">29525649</ArticleId></ArticleIdList></Reference><Reference><Citation>Dores H, Toste A, Cardim N, Portuguese Registry of Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy in Patients with a Normal Electrocardiogram: A View from the East Side of the Atlantic Ocean. 131260Int J Cardiol. 2023;390 doi: 10.1016/j.ijcard.2023.131260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2023.131260</ArticleId><ArticleId IdType="pubmed">37579849</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo O, Marques N, Reis L, Cruz I, Craveiro N, Antunes H, et al. Predictors of Fabry Disease in Patients with Hypertrophic Cardiomyopathy: How to Guide the Diagnostic Strategy? Am Heart J. 2020;226:114&#x2013;126. doi: 10.1016/j.ahj.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2020.04.006</ArticleId><ArticleId IdType="pubmed">32531501</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(4):372&#x2013;389. doi: 10.1016/j.jacc.2021.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.002</ArticleId><ArticleId IdType="pubmed">35086660</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D, Collier P, Thavendiranathan P, Popovic ZB, Hanna M, Plana JC, et al. Relative Apical Sparing of Longitudinal Strain using Two-Dimensional Speckle-Tracking Echocardiography is both Sensitive and Specific for the Diagnosis of Cardiac Amyloidosis. Heart. 2012;98(19):1442&#x2013;1448. doi: 10.1136/heartjnl-2012-302353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-302353</ArticleId><ArticleId IdType="pubmed">22865865</ArticleId></ArticleIdList></Reference><Reference><Citation>Reant P, Mirabel M, Lloyd G, Peyrou J, Lopez Ayala JM, Dickie S, et al. Global Longitudinal Strain is Associated with Heart Failure Outcomes in Hypertrophic Cardiomyopathy. Heart. 2016;102(10):741&#x2013;747. doi: 10.1136/heartjnl-2015-308576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2015-308576</ArticleId><ArticleId IdType="pubmed">26857213</ArticleId></ArticleIdList></Reference><Reference><Citation>Haland TF, Almaas VM, Hasselberg NE, Saberniak J, Leren IS, Hopp E, et al. Strain Echocardiography is Related to Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2016;17(6):613&#x2013;621. doi: 10.1093/ehjci/jew005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jew005</ArticleId><ArticleId IdType="pmc">PMC4871235</ArticleId><ArticleId IdType="pubmed">26873460</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntjens PR, Zhang KW, Soyama Y, Karmpalioti M, Lenihan DJ, Gorcsan J., 3rd Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients with Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2021;14(8):1508&#x2013;1519. doi: 10.1016/j.jcmg.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.01.016</ArticleId><ArticleId IdType="pubmed">33744146</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, et al. A Novel Clinical Method for Quantification of Regional Left Ventricular Pressure-Strain Loop Area: A Non-Invasive Index of Myocardial Work. Eur Heart J. 2012;33(6):724&#x2013;733. doi: 10.1093/eurheartj/ehs016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs016</ArticleId><ArticleId IdType="pmc">PMC3303715</ArticleId><ArticleId IdType="pubmed">22315346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiemstra YL, van der Bijl P, El Mahdiui M, Bax JJ, Delgado V, Marsan NA. Myocardial Work in Nonobstructive Hypertrophic Cardiomyopathy: Implications for Outcome. J Am Soc Echocardiogr. 2020;33(10):1201&#x2013;1208. doi: 10.1016/j.echo.2020.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2020.05.010</ArticleId><ArticleId IdType="pubmed">32680744</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmensen TS, Eiskj&#xe6;r H, Ladefoged B, Mikkelsen F, S&#xf8;rensen J, Granstam SO, et al. Prognostic Implications of Left Ventricular Myocardial Work Indices in Cardiac Amyloidosis. Eur Heart J Cardiovasc Imaging. 2021;22(6):695&#x2013;704. doi: 10.1093/ehjci/jeaa097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa097</ArticleId><ArticleId IdType="pubmed">32529207</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorosz JL, Lezotte DC, Weitzenkamp DA, Allen LA, Salcedo EE. Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction: A Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2012;59(20):1799&#x2013;1808. doi: 10.1016/j.jacc.2012.01.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2012.01.037</ArticleId><ArticleId IdType="pmc">PMC3773600</ArticleId><ArticleId IdType="pubmed">22575319</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampson R, Senior R, Ring L, Robinson S, Augustine DX, Becher H, et al. Contrast Echocardiography: A Practical Guideline from the British Society of Echocardiography. 23Echo Res Pract. 2023;10(1) doi: 10.1186/s44156-023-00034-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s44156-023-00034-9</ArticleId><ArticleId IdType="pmc">PMC10648732</ArticleId><ArticleId IdType="pubmed">37964335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa SA, Thomas B, Pieroni M, Maurizi N, Zampieri M, Cappelli F, et al. Role of Cardiovascular Magnetic Resonance in the Clinical Evaluation of Left Ventricular Hypertrophy: A 360&#xb0; Panorama. Int J Cardiovasc Imaging. 2023;39(4):793&#x2013;809. doi: 10.1007/s10554-022-02774-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-022-02774-x</ArticleId><ArticleId IdType="pubmed">36543912</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical Recommendations for Cardiovascular Magnetic Resonance Mapping of T1, T2, T2* and Extracellular Volume: A Consensus Statement by the Society for Cardiovascular Magnetic Resonance (SCMR) Endorsed by the European Association for Cardiovascular Imaging (EACVI) 75J Cardiovasc Magn Reson. 2017;19(1) doi: 10.1186/s12968-017-0389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-017-0389-8</ArticleId><ArticleId IdType="pmc">PMC5633041</ArticleId><ArticleId IdType="pubmed">28992817</ArticleId></ArticleIdList></Reference><Reference><Citation>Iles LM, Ellims AH, Llewellyn H, Hare JL, Kaye DM, McLean CA, et al. Histological Validation of Cardiac Magnetic Resonance Analysis of Regional and Diffuse Interstitial Myocardial Fibrosis. Eur Heart J Cardiovasc Imaging. 2015;16(1):14&#x2013;22. doi: 10.1093/ehjci/jeu182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu182</ArticleId><ArticleId IdType="pubmed">25354866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;39. doi: 10.1016/j.echo.2014.10.003. e14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017;121(7):749&#x2013;770. doi: 10.1161/CIRCRESAHA.117.311059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311059</ArticleId><ArticleId IdType="pmc">PMC5654557</ArticleId><ArticleId IdType="pubmed">28912181</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes F, Sim&#xf5;es MV, Correia EB, Marcondes-Braga FG, Coelho-Filho OR, Mesquita CT, et al. Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024. Arq Bras Cardiol. 2024;121(7):e202400415. doi: 10.36660/abc.20240415.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20240415</ArticleId><ArticleId IdType="pmc">PMC12092053</ArticleId><ArticleId IdType="pubmed">39082572</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrid MV, Balaram S, Kim B, Axel L, Swistel DG. The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. J Am Coll Cardiol. 2016;67(15):1846&#x2013;1858. doi: 10.1016/j.jacc.2016.01.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.01.071</ArticleId><ArticleId IdType="pubmed">27081025</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberato SH, Romano MMD, Beck ALS, Rodrigues ACT, Almeida ALC, Assun&#xe7;&#xe3;o BMBL, et al. Position Statement on Indications of Echocardiography in Adults - 2019. Arq Bras Cardiol. 2019;113(1):135&#x2013;181. doi: 10.5935/abc.20190129.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/abc.20190129</ArticleId><ArticleId IdType="pmc">PMC6684182</ArticleId><ArticleId IdType="pubmed">31411301</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RK, Shiwani H, Rosmini S, Augusto JB, Burke L, Jiang Y, et al. Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. 2024;17(5):501&#x2013;512. doi: 10.1016/j.jcmg.2023.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.07.012</ArticleId><ArticleId IdType="pubmed">37831014</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna WJ, Kleinebenne A, Nihoyannopoulos P, Foale R. Echocardiographic Measurement of Right Ventricular Wall Thickness in Hypertrophic Cardiomyopathy: Relation to Clinical and Prognostic Features. J Am Coll Cardiol. 1988;11(2):351&#x2013;358. doi: 10.1016/0735-1097(88)90101-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(88)90101-5</ArticleId><ArticleId IdType="pubmed">2963057</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron MS, Hauser TH, Dubrow E, Horst TA, Kissinger KV, Udelson JE, et al. Right Ventricular Involvement in Hypertrophic Cardiomyopathy. Am J Cardiol. 2007;100(8):1293&#x2013;1298. doi: 10.1016/j.amjcard.2007.05.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.05.061</ArticleId><ArticleId IdType="pubmed">17920373</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu M, Kawai H, Yokota Y, Yokoyama M. Echocardiographic Assessment of Right Ventricular Obstruction in Hypertrophic Cardiomyopathy. Circ J. 2003;67(10):855&#x2013;860. doi: 10.1253/circj.67.855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.67.855</ArticleId><ArticleId IdType="pubmed">14578619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosca M, Calin A, Beladan CC, Enache R, Mateescu AD, Gurzun MM, et al. Right Ventricular Remodeling, Its Correlates, and Its Clinical Impact in Hypertrophic Cardiomyopathy. J Am Soc Echocardiogr. 2015;28(11):1329&#x2013;1338. doi: 10.1016/j.echo.2015.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2015.07.015</ArticleId><ArticleId IdType="pubmed">26296986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Park JH. Strain Analysis of the Right Ventricle Using Two-Dimensional Echocardiography. J Cardiovasc Imaging. 2018;26(3):111&#x2013;124. doi: 10.4250/jcvi.2018.26.e11.</Citation><ArticleIdList><ArticleId IdType="doi">10.4250/jcvi.2018.26.e11</ArticleId><ArticleId IdType="pmc">PMC6160817</ArticleId><ArticleId IdType="pubmed">30310878</ArticleId></ArticleIdList></Reference><Reference><Citation>Spirito P, Maron BJ. Relation between Extent of Left Ventricular Hypertrophy and Occurrence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 1990;15(7):1521&#x2013;1526. doi: 10.1016/0735-1097(90)92820-r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(90)92820-r</ArticleId><ArticleId IdType="pubmed">2140576</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Rowin EJ, Maron MS. Evolution of Risk Stratification And Sudden Death Prevention in Hypertrophic Cardiomyopathy: Twenty Years with the Implantable Cardioverter-Defibrillator. Heart Rhythm. 2021;18(6):1012&#x2013;1023. doi: 10.1016/j.hrthm.2021.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.01.019</ArticleId><ArticleId IdType="pubmed">33508516</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Hu K, Nordbeck P, Ertl G, St&#xf6;rk S, Weidemann F. Longitudinal Strain Bull's Eye Plot Patterns in Patients with Cardiomyopathy and Concentric Left Ventricular Hypertrophy. 21Eur J Med Res. 2016;21(1) doi: 10.1186/s40001-016-0216-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-016-0216-y</ArticleId><ArticleId IdType="pmc">PMC4862218</ArticleId><ArticleId IdType="pubmed">27165726</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic Cardiomyopathy is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation. 2006;114(21):2232&#x2013;2239. doi: 10.1161/CIRCULATIONAHA.106.644682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.644682</ArticleId><ArticleId IdType="pubmed">17088454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen SR. Hypertrophic Cardiomyopathy. Curr Probl Cardiol. 2011;36(11):409&#x2013;453. doi: 10.1016/j.cpcardiol.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2011.06.001</ArticleId><ArticleId IdType="pubmed">21962729</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebl VB, Miranda WR, Ong KC, Hodge DO, Bos JM, Gentile F, et al. The Natural History of Nonobstructive Hypertrophic Cardiomyopathy. Mayo Clin Proc. 2016;91(3):279&#x2013;287. doi: 10.1016/j.mayocp.2016.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2016.01.002</ArticleId><ArticleId IdType="pubmed">26944240</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Li D, Berger AE, Johns RA, Gao L. Survival and Prognostic Factors in Hypertrophic Cardiomyopathy: A Meta-Analysis. 11957Sci Rep. 2017;7(1) doi: 10.1038/s41598-017-12289-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12289-4</ArticleId><ArticleId IdType="pmc">PMC5607340</ArticleId><ArticleId IdType="pubmed">28931939</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarta G, Aquaro GD, Pedrotti P, Pontone G, Dellegrottaglie S, Iacovoni A, et al. Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy: the Importance of Clinical Context. Eur Heart J Cardiovasc Imaging. 2018;19(6):601&#x2013;610. doi: 10.1093/ehjci/jex323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jex323</ArticleId><ArticleId IdType="pubmed">29309572</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenezi F, Alajmi H, Agarwal R, Zwischenberger BA. Role of Cardiac Magnetic Resonance (CMR) in Planning Ventricular Septal Myomectomy in Patients with Hypertrophic Obstructive Cardiomyopathy (HOCM) J Card Surg. 2022;37(12):4186&#x2013;4189. doi: 10.1111/jocs.17090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.17090</ArticleId><ArticleId IdType="pubmed">36434805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, et al. A Comprehensive Evaluation of Myocardial Fibrosis in Hypertrophic Cardiomyopathy with Cardiac Magnetic Resonance Imaging: Linking Genotype with Fibrotic Phenotype. Eur Heart J Cardiovasc Imaging. 2014;15(10):1108&#x2013;1116. doi: 10.1093/ehjci/jeu077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu077</ArticleId><ArticleId IdType="pubmed">24819852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, et al. T1 Measurements Identify Extracellular Volume Expansion in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers with and without Left Ventricular Hypertrophy. Circ Cardiovasc Imaging. 2013;6(3):415&#x2013;422. doi: 10.1161/CIRCIMAGING.112.000333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.112.000333</ArticleId><ArticleId IdType="pmc">PMC3769196</ArticleId><ArticleId IdType="pubmed">23549607</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, et al. Prognostic Value of quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients with Hypertrophic Cardiomyopathy. Circulation. 2014;130(6):484&#x2013;495. doi: 10.1161/CIRCULATIONAHA.113.007094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.007094</ArticleId><ArticleId IdType="pubmed">25092278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira PF, Kilner PJ, McGill LA, Nielles-Vallespin S, Scott AD, Ho SY, et al. In Vivo Cardiovascular Magnetic Resonance Diffusion Tensor Imaging Shows Evidence of Abnormal Myocardial Laminar Orientations and Mobility in Hypertrophic Cardiomyopathy. 87J Cardiovasc Magn Reson. 2014;16(1) doi: 10.1186/s12968-014-0087-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-014-0087-8</ArticleId><ArticleId IdType="pmc">PMC4229618</ArticleId><ArticleId IdType="pubmed">25388867</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguiar Rosa S, Thomas B, Fiarresga A, Papoila AL, Alves M, Pereira R, et al. The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy. 761860Front Cardiovasc Med. 2021;8 doi: 10.3389/fcvm.2021.761860.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.761860</ArticleId><ArticleId IdType="pmc">PMC8718511</ArticleId><ArticleId IdType="pubmed">34977179</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaioni C, Knott KD, Augusto JB, Seraphim A, Rosmini S, Ricci F, et al. Inline Perfusion Mapping Provides Insights into the Disease Mechanism in Hypertrophic Cardiomyopathy. Heart. 2020;106(11):824&#x2013;829. doi: 10.1136/heartjnl-2019-315848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315848</ArticleId><ArticleId IdType="pmc">PMC7282549</ArticleId><ArticleId IdType="pubmed">31822572</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SP, Park JB, Kim HK, Kim YJ, Grogan M, Sohn DW. Contemporary Imaging Diagnosis of Cardiac Amyloidosis. J Cardiovasc Imaging. 2019;27(1):1&#x2013;10. doi: 10.4250/jcvi.2019.27.e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.4250/jcvi.2019.27.e9</ArticleId><ArticleId IdType="pmc">PMC6358430</ArticleId><ArticleId IdType="pubmed">30701710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorbala S, Cuddy S, Falk RH. How to Image Cardiac Amyloidosis: A Practical Approach. JACC Cardiovasc Imaging. 2020;13(6):1368&#x2013;1383. doi: 10.1016/j.jcmg.2019.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2019.07.015</ArticleId><ArticleId IdType="pmc">PMC7148180</ArticleId><ArticleId IdType="pubmed">31607664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf5;es MV, Fernandes F, Marcondes-Braga FG, Scheinberg P, Correia EB, Rohde LEP, et al. Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021. Arq Bras Cardiol. 2021;117(3):561&#x2013;598. doi: 10.36660/abc.20210718.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20210718</ArticleId><ArticleId IdType="pmc">PMC8462947</ArticleId><ArticleId IdType="pubmed">34550244</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight DS, Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC Cardiovasc Imaging. 2019;12(5):823&#x2013;833. doi: 10.1016/j.jcmg.2018.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.02.016</ArticleId><ArticleId IdType="pubmed">29680336</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteo S, Anna C, Federico S, Daniele M, Gioele F, Beatrice DP, et al. Stroke Volume and Myocardial Contraction Fraction in Transthyretin Amyloidosis Cardiomyopathy: A Systematic Review. 1085824Front Cardiovasc Med. 2023;10 doi: 10.3389/fcvm.2023.1085824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1085824</ArticleId><ArticleId IdType="pmc">PMC9911429</ArticleId><ArticleId IdType="pubmed">36776259</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo M, Pagura L, Porcari A, Cameli M, Vergaro G, Musumeci B, et al. Unmasking the Prevalence of Amyloid Cardiomyopathy in the Real World: Results from Phase 2 of the AC-TIVE Study, an Italian Nationwide Survey. Eur J Heart Fail. 2022;24(8):1377&#x2013;1386. doi: 10.1002/ejhf.2504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2504</ArticleId><ArticleId IdType="pubmed">35417089</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Hu K, Niemann M, Herrmann S, Cikes M, St&#xf6;rk S, et al. Effect of Combined Systolic and Diastolic Functional Parameter Assessment for Differentiation of Cardiac Amyloidosis from other Causes of Concentric Left Ventricular Hypertrophy. Circ Cardiovasc Imaging. 2013;6(6):1066&#x2013;1072. doi: 10.1161/CIRCIMAGING.113.000683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.000683</ArticleId><ArticleId IdType="pubmed">24100046</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida ALC, Melo MDT, Bihan DCSL, Vieira MLC, Pena JLB, Del Castillo JM, et al. Position Statement on the Use of Myocardial Strain in Cardiology Routines by the Brazilian Society of Cardiology's Department Of Cardiovascular Imaging - 2023. Arq Bras Cardiol. 2023;120(12):e20230646. doi: 10.36660/abc.20230646.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20230646</ArticleId><ArticleId IdType="pmc">PMC10789373</ArticleId><ArticleId IdType="pubmed">38232246</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberato SH, Beck ALS, Hotta VT, Rassi DC. A Critical Review of Echocardiographic Findings for Diagnosing Cardiac Amyloidosis. Int J Cardiovasc Sci. 2024;37:e20240047. doi: 10.36660/ijcs.20240047.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/ijcs.20240047</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotella J, Randazzo M, Maurer MS, Helmke S, Scherrer-Crosbie M, Soltani M, et al. Limitations of Apical Sparing Pattern in Cardiac Amyloidosis: A Multicentre Echocardiographic Study. Eur Heart J Cardiovasc Imaging. 2024;25(6):754&#x2013;761. doi: 10.1093/ehjci/jeae021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeae021</ArticleId><ArticleId IdType="pubmed">38243591</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva AKBB, Cavalcanti LTB, Barberato SH, Felix AS, Melo MDT. The Role of Strain in the Prognosis of Transthyretin Amyloidosis. Int J Cardiovasc Sci. 2024;37:e20240082. doi: 10.36660/ijcs.20240082.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/ijcs.20240082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P, et al. Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016;9(2):126&#x2013;138. doi: 10.1016/j.jcmg.2015.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2015.05.014</ArticleId><ArticleId IdType="pubmed">26777222</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagourelias ED, Mirea O, Duchenne J, Van Cleemput J, Delforge M, Bogaert J, et al. Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters. Circ Cardiovasc Imaging. 2017;10(3):e005588. doi: 10.1161/CIRCIMAGING.116.005588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.116.005588</ArticleId><ArticleId IdType="pubmed">28298286</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbano-Moral JA, Gangadharamurthy D, Comenzo RL, Pandian NG, Patel AR. Three-Dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters. Rev Esp Cardiol. 2015;68(8):657&#x2013;664. doi: 10.1016/j.rec.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2015.01.009</ArticleId><ArticleId IdType="pubmed">26092748</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidsson S, Henein MY, Wikstr&#xf6;m G, Suhr OB, Lindqvist P. Right Ventricular Involvement In Transthyretin Amyloidosis. Amyloid. 2018;25(3):160&#x2013;166. doi: 10.1080/13506129.2018.1493989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2018.1493989</ArticleId><ArticleId IdType="pubmed">30193533</ArticleId></ArticleIdList></Reference><Reference><Citation>White JA, Kim HW, Shah D, Fine N, Kim KY, Wendell DC, et al. CMR Imaging with Rapid Visual T1 Assessment Predicts Mortality in Patients Suspected of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2014;7(2):143&#x2013;156. doi: 10.1016/j.jcmg.2013.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2013.09.019</ArticleId><ArticleId IdType="pmc">PMC3951756</ArticleId><ArticleId IdType="pubmed">24412191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015;132(16):1570&#x2013;1579. doi: 10.1161/CIRCULATIONAHA.115.016567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.016567</ArticleId><ArticleId IdType="pmc">PMC4606985</ArticleId><ArticleId IdType="pubmed">26362631</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, Kerwin MJ, Salerno M. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis. JACC Cardiovasc Imaging. 2020;13(6):1299&#x2013;1310. doi: 10.1016/j.jcmg.2020.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.03.010</ArticleId><ArticleId IdType="pmc">PMC7340140</ArticleId><ArticleId IdType="pubmed">32498919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko L, Boldrini M, Martone R, Law S, Martinez-Naharrro A, Hutt DF, et al. Cardiac Magnetic Resonance-Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid. Circ Cardiovasc Imaging. 2021:CIRCIMAGING121012506. doi: 10.1161/CIRCIMAGING.121.012506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.121.012506</ArticleId><ArticleId IdType="pubmed">33876651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou A, Patel RK, Razvi Y, Porcari A, Knight D, Martinez-Naharro A, et al. Multi-Imaging Characterization of Cardiac Phenotype in Different Types of Amyloidosis. JACC Cardiovasc Imaging. 2023;16(4):464&#x2013;477. doi: 10.1016/j.jcmg.2022.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.07.008</ArticleId><ArticleId IdType="pubmed">36648052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzantonis G, Bietenbeck M, Elsanhoury A, Tsch&#xf6;pe C, Pieske B, Tauscher G, et al. Diagnostic Value of Cardiovascular Magnetic Resonance in Comparison to Endomyocardial Biopsy In Cardiac Amyloidosis: A Multi-Centre Study. Clin Res Cardiol. 2021;110(4):555&#x2013;568. doi: 10.1007/s00392-020-01771-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01771-1</ArticleId><ArticleId IdType="pmc">PMC8055632</ArticleId><ArticleId IdType="pubmed">33170349</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo O, Cordeiro F, Gago MF, Miltenberger-Miltenyi G, Ferreira C, Sousa N, et al. Fabry Disease and the Heart: A Comprehensive Review. 4434Int J Mol Sci. 2021;22(9) doi: 10.3390/ijms22094434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094434</ArticleId><ArticleId IdType="pmc">PMC8123068</ArticleId><ArticleId IdType="pubmed">33922740</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, et al. The Effect of Enzyme Replacement Therapy on Clinical Outcomes in Male Patients with Fabry Disease: A Systematic Literature Review by a European Panel of Experts. 100454Mol Genet Metab Rep. 2019;19 doi: 10.1016/j.ymgmr.2019.100454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgmr.2019.100454</ArticleId><ArticleId IdType="pmc">PMC6365982</ArticleId><ArticleId IdType="pubmed">30775256</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziani F, Laurito M, Pieroni M, Pennestr&#xec; F, Lanza GA, Coluccia V, et al. Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study. J Am Soc Echocardiogr. 2017;30(3):282&#x2013;291. doi: 10.1016/j.echo.2016.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2016.11.014</ArticleId><ArticleId IdType="pubmed">28069318</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R, Shah R, Saiedi M, Patil S, Ganesan A, Linhart A, et al. The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease. JACC Cardiovasc Imaging. 2019;12(7 Pt 1):1230&#x2013;1242. doi: 10.1016/j.jcmg.2018.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.11.039</ArticleId><ArticleId IdType="pubmed">31272606</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin S, Kozor R, Medina-Menacho K, Abdel-Gadir A, Baig S, Sado DM, et al. Proposed Stages of Myocardial Phenotype Development in Fabry Disease. JACC Cardiovasc Imaging. 2019;12(8 Pt 2):1673&#x2013;1683. doi: 10.1016/j.jcmg.2018.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.03.020</ArticleId><ArticleId IdType="pubmed">29778854</ArticleId></ArticleIdList></Reference><Reference><Citation>Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W. Cardiologic Abnormalities in Noonan Syndrome: Phenotypic Diagnosis and Echocardiographic Assessment of 118 Patients. J Am Coll Cardiol. 1993;22(4):1189&#x2013;1192. doi: 10.1016/0735-1097(93)90436-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(93)90436-5</ArticleId><ArticleId IdType="pubmed">8409059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin AE, Basson CT, Goldmuntz E, Magoulas PL, McDermott DA, McDonald-McGinn DM, et al. Adults with Genetic Syndromes and Cardiovascular Abnormalities: Clinical History and Management. Genet Med. 2008;10(7):469&#x2013;494. doi: 10.1097/gim.0b013e3181772111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/gim.0b013e3181772111</ArticleId><ArticleId IdType="pmc">PMC2671242</ArticleId><ArticleId IdType="pubmed">18580689</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb BD, Roberts AE, Tartaglia M. Cardiomyopathies in Noonan Syndrome and the other RASopathies. Prog Pediatr Cardiol. 2015;39(1):13&#x2013;19. doi: 10.1016/j.ppedcard.2015.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2015.01.002</ArticleId><ArticleId IdType="pmc">PMC4568836</ArticleId><ArticleId IdType="pubmed">26380542</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino B, Gagliardi MG, Digilio MC, Polletta B, Grazioli S, Agostino D, et al. Noonan Syndrome: Structural Abnormalities of the Mitral Valve Causing Subaortic Obstruction. Eur J Pediatr. 1995;154(12):949&#x2013;952. doi: 10.1007/BF01958636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01958636</ArticleId><ArticleId IdType="pubmed">8801101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson JD, Lowe AM, Salbert BA, Sleeper LA, Colan SD, Cox GF, et al. Outcomes in Children with Noonan Syndrome and Hypertrophic Cardiomyopathy: A Study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2012;164(3):442&#x2013;448. doi: 10.1016/j.ahj.2012.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2012.04.018</ArticleId><ArticleId IdType="pubmed">22980313</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendiville TW, Gauvreau K, Tworog-Dube E, Patkin L, Kucherlapati RS, Roberts AE, et al. Cardiovascular Disease in Noonan Syndrome. Arch Dis Child. 2014;99(7):629&#x2013;634. doi: 10.1136/archdischild-2013-305047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2013-305047</ArticleId><ArticleId IdType="pubmed">24534818</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffers LE, Kok R, van den Berg LE, van den Hout JMP, Boersma E, van Capelle CI, et al. Effects of Enzyme Replacement Therapy on Cardiac Function in Classic Infantile Pompe Disease. Int J Cardiol. 2023;380:65&#x2013;71. doi: 10.1016/j.ijcard.2023.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2023.03.010</ArticleId><ArticleId IdType="pubmed">36893858</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena JLB, Santos WC, Siqueira MHA, Sampaio IH, Moura ICG, Sternick EB. Glycogen Storage Cardiomyopathy (PRKAG2): Diagnostic Findings of Standard and Advanced Echocardiography Techniques. Eur Heart J Cardiovasc Imaging. 2021;22(7):800&#x2013;807. doi: 10.1093/ehjci/jeaa176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa176</ArticleId><ArticleId IdType="pubmed">32747946</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Bai R, Wang L, Zhang C, Zhao R, Wan D, et al. Identification of a Novel de Novo Mutation Associated with PRKAG2 Cardiac Syndrome and Early Onset of Heart Failure. PLoS One. 2013;8(5):e64603. doi: 10.1371/journal.pone.0064603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064603</ArticleId><ArticleId IdType="pmc">PMC3669303</ArticleId><ArticleId IdType="pubmed">23741347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogasundaram H, Paterson ID, Graham M, Sergi C, Oudit GY. Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block. Circ Heart Fail. 2016;9(8):e003367. doi: 10.1161/CIRCHEARTFAILURE.116.003367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.003367</ArticleId><ArticleId IdType="pubmed">27496753</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena JLB, Melo FJ, Santos WC, Moura ICG, Nakashima GP, Freitas NC, et al. Right Ventricle Involvement by Glycogen Storage Cardiomyopathy (PRKAG2): Standard and Advanced Echocardiography Analyses. Arq Bras Cardiol. 2022;119(6):902&#x2013;909. doi: 10.36660/abc.20210801.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20210801</ArticleId><ArticleId IdType="pmc">PMC9814818</ArticleId><ArticleId IdType="pubmed">36417616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang L, Li X, Zhou N, Jiang Y, Pan C, Shu X. Echocardiographic Characteristics of PRKAG2 Syndrome: A Research using Three-Dimensional Speckle Tracking Echocardiography compared with Sarcomeric Hypertrophic Cardiomyopathy. 14Cardiovasc Ultrasound. 2022;20(1) doi: 10.1186/s12947-022-00284-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12947-022-00284-3</ArticleId><ArticleId IdType="pmc">PMC9069802</ArticleId><ArticleId IdType="pubmed">35509080</ArticleId></ArticleIdList></Reference><Reference><Citation>Casazza F, Morpurgo M. The Varying Evolution of Friedreich's Ataxia Cardiomyopathy. Am J Cardiol. 1996;77(10):895&#x2013;898. doi: 10.1016/S0002-9149(97)89194-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(97)89194-1</ArticleId><ArticleId IdType="pubmed">8623752</ArticleId></ArticleIdList></Reference><Reference><Citation>Riba&#xef; P, Pousset F, Tanguy ML, Rivaud-Pechoux S, Le Ber I, Gasparini F, et al. Neurological, Cardiological, and Oculomotor Progression in 104 Patients with Friedreich Ataxia during Long-Term Follow-Up. Arch Neurol. 2007;64(4):558&#x2013;564. doi: 10.1001/archneur.64.4.558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.4.558</ArticleId><ArticleId IdType="pubmed">17420319</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P. Normal Left Ventricular Ejection Fraction and Mass but Subclinical Myocardial Dysfunction in Patients with Friedreich's Ataxia. Eur Heart J Cardiovasc Imaging. 2012;13(4):346&#x2013;352. doi: 10.1093/ejechocard/jer267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jer267</ArticleId><ArticleId IdType="pubmed">22127629</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman SV, Phatak K, Hoyle JC, Pennell ML, McCarthy B, Tran T, et al. Impaired Myocardial Perfusion Reserve and Fibrosis in Friedreich Ataxia: A Mitochondrial Cardiomyopathy with Metabolic Syndrome. Eur Heart J. 2011;32(5):561&#x2013;567. doi: 10.1093/eurheartj/ehq443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq443</ArticleId><ArticleId IdType="pmc">PMC3106287</ArticleId><ArticleId IdType="pubmed">21156720</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidemann F, Rummey C, Bijnens B, St&#xf6;rk S, Jasaityte R, Dhooge J, et al. The Heart in Friedreich Ataxia: Definition of cardiomyopathy, Disease Severity, and Correlation with Neurological Symptoms. Circulation. 2012;125(13):1626&#x2013;1634. doi: 10.1161/CIRCULATIONAHA.111.059477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.059477</ArticleId><ArticleId IdType="pubmed">22379112</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidemann F, Breunig F, Beer M, Sandstede J, St&#xf6;rk S, Voelker W, et al. The Variation of Morphological and Functional Cardiac Manifestation in Fabry Disease: Potential Implications for the Time Course of the Disease. Eur Heart J. 2005;26(12):1221&#x2013;1227. doi: 10.1093/eurheartj/ehi143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi143</ArticleId><ArticleId IdType="pubmed">15728649</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhai N, Wang X, Wang J, Jiang M, Sun Z, et al. Cardiovascular Magnetic Resonance Findings in Danon Disease: A Case Series of a Family. 1159576Front Cardiovasc Med. 2023;10 doi: 10.3389/fcvm.2023.1159576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1159576</ArticleId><ArticleId IdType="pmc">PMC10192707</ArticleId><ArticleId IdType="pubmed">37215540</ArticleId></ArticleIdList></Reference><Reference><Citation>Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S, et al. Lysosomal Glycogen Storage Disease with Normal Acid Maltase. Neurology. 1981;31(1):51&#x2013;57. doi: 10.1212/wnl.31.1.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.31.1.51</ArticleId><ArticleId IdType="pubmed">6450334</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Xu J, Chen L, Ji K, Fan X, Zhao S, et al. Clinical Features and Cardiovascular Magnetic Resonance Characteristics in Danon Disease. Clin Radiol. 2020;75(9):712.e1&#x2013;712.e11. doi: 10.1016/j.crad.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crad.2020.04.012</ArticleId><ArticleId IdType="pubmed">32499120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, Zhao L, Xie J, Liu Y, Du Z, Zhong X, et al. Cardiac Phenotype Characterization at MRI in Patients with Danon Disease: A Retrospective Multicenter Case Series. Radiology. 2021;299(2):303&#x2013;310. doi: 10.1148/radiol.2021203996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203996</ArticleId><ArticleId IdType="pubmed">33754825</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucifora G, Miani D, Piccoli G, Proclemer A. Cardiac Magnetic Resonance Imaging in Danon Disease. Cardiology. 2012;121(1):27&#x2013;30. doi: 10.1159/000336448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000336448</ArticleId><ArticleId IdType="pubmed">22378182</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40064169</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1665-1146</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>1</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Boletin medico del Hospital Infantil de Mexico</Title><ISOAbbreviation>Bol Med Hosp Infant Mex</ISOAbbreviation></Journal><ArticleTitle>Hydrocele of the canal of Nuck: a case report of an unusual disease.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>66</EndPage><MedlinePgn>63-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/BMHIM.24000078</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hydrocele of the canal of Nuck is a rare pathology with a prevalence of approximately 1% in females aged 0-16 years. Its prevalence in adults remains unknown. The condition develops due to persistent patency or failed obliteration of the canal of Nuck. Several factors may contribute to its development, including lymphatic disorders, trauma, infection, inflammation, or idiopathic causes. Clinically, it presents as edema in the groin or genital region without additional symptoms. Ultrasonography is the preferred diagnostic modality for hydrocele of the canal of Nuck.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="METHODS">We present the case of a 20-month-old female patient who presented with pain and a "lump" in the right inguinal region for 3 days. The patient was diagnosed with type 1 hydrocele of the canal of Nuck through ultrasonography, which was subsequently confirmed during surgery. The patient was discharged on the same day as the procedure and remains asymptomatic.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although rare, hydrocele of the canal of Nuck should be considered in the differential diagnosis of groin or genital region edema presenting without additional symptoms. Its diagnosis can be challenging due to several common differential diagnoses, including indirect inguinal hernia, tumors, cysts, abscesses, and lymphadenopathies, which occur more frequently. Therefore, ultrasonography plays a crucial role in evaluating these differential diagnoses and confirming the hydrocele of the canal of Nuck.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Permanyer.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suda-Rodrigues</LastName><ForeName>Bruna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Ultrasonography, Irmandade da Santa Casa de Miseric&#xf3;rdia de Santos, Santos (SP).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Ponte</LastName><ForeName>Ma Beatriz Ferraz-Cabral</ForeName><Initials>MBF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Universidade Metropolitana de Santos, Santos (SP).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>M&#xe1;rcio L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Radiology, Universidade de Ribeir&#xe3;o Preto - Campus Guaruj&#xe1;, Guaruj&#xe1; (SP); Department of Radiology, Diagn&#xf3;sticos da Am&#xe9;rica S.A., S&#xe3;o Paulo (SP). Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>&#xc9;lcio R</ForeName><Initials>&#xc9;R</Initials><AffiliationInfo><Affiliation>Department of Ultrasonography, Irmandade da Santa Casa de Miseric&#xf3;rdia de Santos, Santos (SP).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><VernacularTitle>Hidrocele del canal de Nuck: informe de caso de una enfermedad poco com&#xfa;n.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Bol Med Hosp Infant Mex</MedlineTA><NlmUniqueID>0414106</NlmUniqueID><ISSNLinking>0539-6115</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004487" MajorTopicYN="Y">Edema</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007264" MajorTopicYN="Y">Inguinal Canal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N" NlmCategory="UNASSIGNED">El hidrocele del canal de Nuck es una patolog&#xed;a rara con una prevalencia aproximada del 1% en mujeres de 0 a 16 a&#xf1;os. Su prevalencia en adultos a&#xfa;n se desconoce. La afecci&#xf3;n se desarrolla debido a una permeabilidad persistente o a una obliteraci&#xf3;n fallida del canal de Nuck. Varios factores pueden contribuir a su desarrollo, como trastornos linf&#xe1;ticos, traumatismos, infecciones, inflamaciones o causas idiop&#xe1;ticas. Cl&#xed;nicamente, se presenta como un edema en la ingle o en la regi&#xf3;n genital sin s&#xed;ntomas adicionales. La ecograf&#xed;a es la modalidad diagn&#xf3;stica preferida para el hidrocele del canal de Nuck.</AbstractText><AbstractText Label="CASO CL&#xcd;NICO" NlmCategory="UNASSIGNED">Presentamos el caso de una paciente de 20 meses de edad que present&#xf3; dolor y un &#x201c;bulto&#x201d; en la regi&#xf3;n inguinal derecha durante tres d&#xed;as. Se le diagnostic&#xf3; hidrocele del canal de Nuck de tipo 1 mediante ecograf&#xed;a, que se confirm&#xf3; posteriormente durante la intervenci&#xf3;n quir&#xfa;rgica. El paciente fue dado de alta el mismo d&#xed;a de la intervenci&#xf3;n y permanece asintom&#xe1;tico.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">Aunque poco frecuente, el hidrocele del canal de Nuck debe considerarse en el diagn&#xf3;stico diferencial del edema inguinal o de la regi&#xf3;n genital que se presenta sin s&#xed;ntomas adicionales. Su diagn&#xf3;stico puede ser dif&#xed;cil debido a varios diagn&#xf3;sticos diferenciales comunes, incluida la hernia inguinal indirecta, tumores, quistes, abscesos y linfadenopat&#xed;as, que se presentan con mayor frecuencia. Por lo tanto, la ecograf&#xed;a desempe&#xf1;a un papel crucial en la evaluaci&#xf3;n de estos diagn&#xf3;sticos diferenciales y la confirmaci&#xf3;n del hidrocele del canal de Nuck.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Permanyer.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Hidrocele del canal de Nuck</Keyword><Keyword MajorTopicYN="N">Hydrocele of the canal of Nuck</Keyword><Keyword MajorTopicYN="N">Reporte de caso</Keyword><Keyword MajorTopicYN="N">Ultrasonograf&#xed;a</Keyword><Keyword MajorTopicYN="N">Ultrasonography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>11</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>11</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>10</Day><Hour>19</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40064169</ArticleId><ArticleId IdType="doi">10.24875/BMHIM.24000078</ArticleId><ArticleId IdType="pii">j82/1/63</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39932215</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Cancer Incidence and Mortality in Familial Adenomatous Polyposis Syndrome.</ArticleTitle><Pagination><StartPage>531</StartPage><EndPage>543</EndPage><MedlinePgn>531-543</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003645</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Risk-reducing colectomy in familial adenomatous polyposis syndrome is the standard of care. This has increased the importance of surveillance for extracolonic malignancies in postcolectomy individuals.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to define the present-day incidence of all cancers and mortality in familial adenomatous polyposis.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective longitudinal cohort study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Two large academic hospitals.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Eligible patients carried an APC pathogenic variant or met clinical criteria for familial adenomatous polyposis.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Cancer diagnosis, mortality, and associated risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 358 patients were identified. The percentage who exhibited a classic familial adenomatous polyposis phenotype was 63.7%; 21.2% were de novo, and 82.7% had a colectomy. Colorectal cancer was the most common cancer (n = 59; 16.5%). Colorectal cancer diagnoses were associated with de novo familial adenomatous polyposis (OR 7.8 [95% CI, 3.51-17.35]; p &lt; 0.001). Thyroid, duodenal/small bowel, gastric, and neuroendocrine tumors were reported in 7.5%, 3.1%, 2.8%, and 2.5% of patients, respectively. Rates of cancer were similar in classic and attenuated familial adenomatous polyposis. Thirty-nine patients (10.9%) died at a mean age of 49.6 &#xb1; 17.1 years. Twenty-six deaths were malignancy-related, and colorectal cancer was the leading cause (n = 10). All colorectal cancer-related deaths occurred in individuals with classic familial adenomatous polyposis, and 9 of 10 individuals were not previously diagnosed with the syndrome. Gastric and duodenal/small bowel cancers were the second leading causes (4 deaths each), and all occurred after colectomy. Fifty-nine percent of all deaths were attributable to a familial adenomatous polyposis-related malignancy or morbidity.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective clinical data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Colorectal cancer remains the most common malignancy and cause of death in familial adenomatous polyposis. However, nearly all colorectal cancer-related deaths occurred in individuals unaware of their familial adenomatous polyposis diagnosis, and none occurred in the attenuated syndrome. In patients who had a colectomy, gastric and duodenal/small bowel cancers are now the leading causes of death. See Video Abstract .</AbstractText><AbstractText Label="INCIDENCIA Y MORTALIDAD POR CNCER EN EL SNDROME DE POLIPOSIS ADENOMATOSA FAMILIAR" NlmCategory="UNASSIGNED">ANTECEDENTES:La colectom&#xed;a para reducir el riesgo en el s&#xed;ndrome de poliposis adenomatosa familiar es el est&#xe1;ndar de atenci&#xf3;n. Esto ha aumentado la importancia de la vigilancia de las neoplasias malignas extracol&#xf3;nicas en individuos post-colectom&#xed;a.OBJETIVO:Buscamos definir la incidencia actual de todos los c&#xe1;nceres y la mortalidad en la poliposis adenomatosa familiar.DISE&#xd1;O:Estudio de cohorte longitudinal retrospectivo.ESCENARIO:Dos grandes hospitales acad&#xe9;micos.PACIENTES:Los pacientes elegibles portaban una variante patog&#xe9;nica de APC o cumpl&#xed;an los criterios cl&#xed;nicos para la poliposis adenomatosa familiar.PRINCIPALES MEDIDAS DE RESULTADOS:Diagn&#xf3;stico de c&#xe1;ncer, mortalidad,y factores de riesgo asociados.RESULTADOS:Se identificaron 358 pacientes. El 63,7% presentaban un fenotipo cl&#xe1;sico de poliposis adenomatosa familiar, el 21,2% eran de novo y el 82,7% se hab&#xed;a sometido a una colectom&#xed;a. El c&#xe1;ncer colorrectal fue el c&#xe1;ncer m&#xe1;s com&#xfa;n (n = 59, 16,5%). Los diagn&#xf3;sticos de c&#xe1;ncer colorrectal se asociaron con poliposis adenomatosa familiar de novo (odds ratio 7,8 (IC del 95 % 3,51-17,35; p &lt; 0,001)). Se informaron tumores de tiroides, duodenales/intestino delgado, g&#xe1;stricos y neuroendocrinos en el 7,5 %, 3,1 %, 2,8 % y 2,5 % de los pacientes, respectivamente. Las tasas de c&#xe1;ncer fueron similares en la poliposis adenomatosa familiar cl&#xe1;sica y atenuada. 39 pacientes (10,9 %) murieron a una edad media de 49,6 &#xb1; 17,1 a&#xf1;os. 26 muertes estuvieron relacionadas con neoplasias malignas y el c&#xe1;ncer colorrectal fue la causa principal (n = 10). Todas las muertes relacionadas con c&#xe1;ncer colorrectal ocurrieron en individuos con poliposis adenomatosa familiar cl&#xe1;sica y 9/10 no hab&#xed;an sido diagnosticados previamente con el s&#xed;ndrome. El c&#xe1;ncer g&#xe1;strico y de duodeno/intestino delgado fueron las segundas causas principales (4 muertes cada uno), y todas ocurrieron despu&#xe9;s de una colectom&#xed;a. El 59% de todas las muertes fueron atribuibles a una neoplasia maligna o morbilidad relacionada con la poliposis adenomatosa familiar.LIMITACIONES:Datos cl&#xed;nicos retrospectivos.CONCLUSIONES:El c&#xe1;ncer colorrectal sigue siendo la neoplasia maligna y la causa de muerte m&#xe1;s com&#xfa;n en la poliposis adenomatosa familiar. Sin embargo, casi todas las muertes relacionadas con el c&#xe1;ncer colorrectal ocurrieron en personas que desconoc&#xed;an su diagn&#xf3;stico de poliposis adenomatosa familiar, y ninguna ocurri&#xf3; en el s&#xed;ndrome atenuado. En los pacientes que se sometieron a una colectom&#xed;a, los c&#xe1;nceres g&#xe1;strico y de duodeno/intestino delgado son ahora las principales causas de muerte. (Traducci&#xf3;n-Dr Yolanda Colorado ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feldman</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7842-4941</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodgers-Fouche</LastName><ForeName>Linda H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Center for Cancer Risk Assessment, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukaegbu</LastName><ForeName>Chinedu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1629-2824</Identifier><AffiliationInfo><Affiliation>Cancer Genetics and Prevention Division, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yurgelun</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0002-6184-9273</Identifier><AffiliationInfo><Affiliation>Cancer Genetics and Prevention Division, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syngal</LastName><ForeName>Sapna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5487-7471</Identifier><AffiliationInfo><Affiliation>Cancer Genetics and Prevention Division, Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Daniel C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cancer Risk Assessment, Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011125" MajorTopicYN="Y">Adenomatous Polyposis Coli</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="N">Colectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013964" MajorTopicYN="N">Thyroid Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013274" MajorTopicYN="N">Stomach Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cancer incidence</Keyword><Keyword MajorTopicYN="N">Colorectal cancer</Keyword><Keyword MajorTopicYN="N">Familial adenomatous polyposis</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>11</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>11</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39932215</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003645</ArticleId><ArticleId IdType="pii">00003453-990000000-00867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jasperson KW, Patel SG, Ahnen DJ. APC-associated polyposis conditions. Atlas Genet Cytogenet Oncol Haematol. 2017;24:477&#x2013;482.</Citation></Reference><Reference><Citation>Gupta S, Weiss JM, Axel L, et al. NCCN guidelines: genetic/familial high-risk assessment: colorectal, endometrial, and gastric (version 3.2024). National Comprehensive Cancer Network (NCCN). 2023. https://www.nccn.org/guidelines/guidelines-detail?category=2&amp;id=1544 . Accessed January 31, 2025.</Citation></Reference><Reference><Citation>Dinarvand P, Davaro EP, Doan JV, et al. Familial adenomatous polyposis syndrome an update and review of extraintestinal manifestations. Arch Pathol Lab Med. 2019;143:1382&#x2013;1398.</Citation></Reference><Reference><Citation>Aretz S, Uhlhaas S, Caspari R, et al. Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet. 2004;12:52&#x2013;58.</Citation></Reference><Reference><Citation>Matsubara T, Beppu N, Ikeda M, et al. Current clinical practice for familial adenomatous polyposis in Japan: a nationwide multicenter study. Ann Gastroenterol Surg. 2022;6:778&#x2013;787.</Citation></Reference><Reference><Citation>Paszkowski J, Samborski P, Kucharski M, Cwali&#x144;ski J, Banasiewicz T, P&#x142;awski A. Endoscopic surveillance and treatment of upper GI tract lesions in patients with familial adenomatous polyposis&#x2014;a new perspective on an old disease. Genes (Basel). 2022;13:2329.</Citation></Reference><Reference><Citation>Yoon JY, Mehta N, Burke CA, et al. The prevalence and significance of jejunal and duodenal bulb polyposis after duodenectomy in familial adenomatous polyposis retrospective cohort study. Ann Surg. 2021;274:e1071&#x2013;e1077.</Citation></Reference><Reference><Citation>B&#xfc;low S, Christensen IJ, H&#xf8;jen H, et al. Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis. Colorectal Dis. 2012;14:947&#x2013;952.</Citation></Reference><Reference><Citation>Mankaney G, Leone P, Cruise M, et al. Gastric cancer in FAP: a concerning rise in incidence. Fam Cancer. 2017;16:371&#x2013;376.</Citation></Reference><Reference><Citation>Yang J, Gurudu SR, Koptiuch C, et al. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes. Gastrointest Endosc. 2020;91:963&#x2013;982.e2.</Citation></Reference><Reference><Citation>Cannon AR, Keener M, Neklason D, Pickron TB. Surgical interventions, malignancies, and causes of death in a FAP patient registry. J Gastrointest Surg. 2021;25:452&#x2013;456.</Citation></Reference><Reference><Citation>Nieuwenhuis MH, Lefevre JH, B&#xfc;low S, et al. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum. 2011;54:1229&#x2013;1234.</Citation></Reference><Reference><Citation>Aelvoet AS, Struik D, Bastiaansen BAJ, et al. Colectomy and desmoid tumours in familial adenomatous polyposis: a systematic review and meta-analysis. Fam Cancer. 2022;21:429&#x2013;439.</Citation></Reference><Reference><Citation>Anele CC, Martin I, McGinty Duggan PM, et al. Attenuated familial adenomatous polyposis: a phenotypic diagnosis but obsolete term? Dis Colon Rectum. 2022;65:529&#x2013;535.</Citation></Reference><Reference><Citation>Roncucci L, Pedroni M, Mariani F. Attenuated adenomatous polyposis of the large bowel: present and future. World J Gastroenterol. 2017;23:4135&#x2013;4139.</Citation></Reference><Reference><Citation>Spigelman AD, Talbot IC, Williams CB, Domizio P, Phillips RKS. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;334:783&#x2013;785.</Citation></Reference><Reference><Citation>DelSignore M, Jeong T, Denmark G, et al. Incidence and natural history of gastric high-grade dysplasia in patients with familial adenomatous polyposis syndrome. Gastrointest Endosc. 2023;97:25&#x2013;34.e6.</Citation></Reference><Reference><Citation>Knudsen AL, B&#xfc;low S, Tomlinson I, M&#xf6;slein G, Heinimann K, Christensen IJ; AFAP Study Group. Attenuated familial adenomatous polyposis: results from an international collaborative study. Colorectal Dis. 2010;12:e243&#x2013;e249.</Citation></Reference><Reference><Citation>Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405&#x2013;424.</Citation></Reference><Reference><Citation>Yen T, Stanich PP, Axell L, et al. APC-associated polyposis conditions. Atlas Genet Cytogenet Oncol Haematol. 2022;24:477&#x2013;482.</Citation></Reference><Reference><Citation>Jin XF, Spoettl G, Mauerer J, N&#xf6;lting S, Auernhammer CJ. Inhibition of Wnt/&#x3b2;-catenin signaling in neuroendocrine tumors in vitro: antitumoral effects. Cancers. 2020;12:345.</Citation></Reference><Reference><Citation>Das S, Dasari A. Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep. 2021;23:43.</Citation></Reference><Reference><Citation>Nawata Y, Ichihara S, Hirasawa D, et al. A case of gastric adenocarcinoma considered to originate from a sporadic fundic gland polyp in a Helicobacter pylori -uninfected stomach. Clin J Gastroenterol. 2020;13:740&#x2013;745.</Citation></Reference><Reference><Citation>Baptista D, Fernandes M, Garrido M, et al. Gastric polyps in familial adenomatous polyposis Portuguese patients: the first western cohort with Asian features. Pathobiology. 2024;91:196&#x2013;204.</Citation></Reference><Reference><Citation>Leone PJ, Mankaney G, Sarvapelli S, et al. Endoscopic and histologic features associated with gastric cancer in familial adenomatous polyposis. Gastrointest Endosc. 2019;89:961&#x2013;968.</Citation></Reference><Reference><Citation>Mankaney GN, Cruise M, Sarvepalli S, et al. Surveillance for pathology associated with cancer on endoscopy (SPACE): criteria to identify high-risk gastric polyps in familial adenomatous polyposis. Gastrointest Endosc. 2020;92:755&#x2013;762.</Citation></Reference><Reference><Citation>Martin I, Roos VH, Anele C, et al. Gastric adenomas and their management in familial adenomatous polyposis. Endoscopy. 2021;53:795&#x2013;801.</Citation></Reference><Reference><Citation>Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum. 1990;33:639&#x2013;642.</Citation></Reference><Reference><Citation>Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg. 1993;217:101&#x2013;108.</Citation></Reference><Reference><Citation>B&#xfc;low S. Results of national registration of familial adenomatous polyposis. Gut. 2003;52:742&#x2013;746.</Citation></Reference><Reference><Citation>Ghorbanoghli Z, Bastiaansen BAJ, Langers AMJ, et al. Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis. J Med Genet. 2018;55:11&#x2013;14.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39531556</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2590-7379</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>Biomedica : revista del Instituto Nacional de Salud</Title><ISOAbbreviation>Biomedica</ISOAbbreviation></Journal><ArticleTitle>Concordance between clinical diagnoses and autopsies anatomopathological findings at a tertiary-level university hospital.</ArticleTitle><Pagination><StartPage>486</StartPage><EndPage>495</EndPage><MedlinePgn>486-495</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7705/biomedica.7097</ELocationID><Abstract><AbstractText Label="INTRODUCTION">A clinical autopsy is a fundamental diagnostic tool for confirming the diagnosis of diseases of public health interest. However, the clinical-pathological concordance has not been evaluated.</AbstractText><AbstractText Label="OBJECTIVE">To determine the concordance between clinical diagnoses and anatomopathological findings from autopsies conducted at a tertiary-level hospital institution.</AbstractText><AbstractText Label="MATERIALS AND METHODS">A descriptive, observational, cross-sectional, and retrospective study where we analyzed autopsy cases performed between 2015 and 2019. The variables studied were age, gender, origin, and clinical and anatomopathological diagnoses.</AbstractText><AbstractText Label="RESULTS">The concordance degree was slight (&#x3ba; = 0.30; 95% CI: 0.21-0.42), which coincides with internationally reported findings in healthcare institutions with a similar patient population and availability of diagnostic resources. The clinical-pathological discrepancy, as evidenced according to the Goldman et al. classification, then modified by Battle et al., was 57.3% (47/82), corresponding to major discrepancies, a value within the expected limits.</AbstractText><AbstractText Label="CONCLUSIONS">The concordance between clinical diagnoses and anatomopathological findings in autopsies is slight, and the discrepancies are within the expected range. This study highlights the importance of improving clinical and syndromic diagnosis of public health interest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Julieth Alexandra</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-6949-2953</Identifier><AffiliationInfo><Affiliation>Departamento de Patolog&#xed;a, Universidad Remington, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>Mario Miguel</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-1211-3681</Identifier><AffiliationInfo><Affiliation>Centro de Investigaciones Cl&#xed;nicas, Fundaci&#xf3;n Valle del Lili, Cali, Colombia; Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia; Divisi&#xf3;n de Traumatolog&#xed;a y Cirug&#xed;a de Cuidados Intensivos, Departamento de Cirug&#xed;a, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redondo</LastName><ForeName>Cesar</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0494-5047</Identifier><AffiliationInfo><Affiliation>Departamento de Patolog&#xed;a, Universidad de Cartagena, Cartagena de Indias, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Concordancia entre los diagn&#xf3;sticos cl&#xed;nico y anatomopatol&#xf3;gico en autopsias realizadas en un hospital universitario.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Biomedica</MedlineTA><NlmUniqueID>8205605</NlmUniqueID><ISSNLinking>0120-4157</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="Y">Autopsy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="Y">Hospitals, University</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="Y">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N">La autopsia cl&#xed;nica es una ayuda fundamental para confirmar el diagn&#xf3;stico de enfermedades de inter&#xe9;s en salud p&#xfa;blica. Sin embargo, la concordancia cl&#xed;nico-patol&#xf3;gica no ha sido evaluada.</AbstractText><AbstractText Label="OBJETIVO">Determinar la concordancia entre los diagn&#xf3;sticos cl&#xed;nicos y los hallazgos anatomopatol&#xf3;gicos de autopsias en una instituci&#xf3;n hospitalaria de tercer nivel.</AbstractText><AbstractText Label="MATERIALES Y M&#xc9;TODOS">Se desarroll&#xf3; un estudio descriptivo, observacional, transversal y retrospectivo, en el cual se analizaron las autopsias practicadas entre el 2015 y el 2019. Las variables estudiadas fueron: edad, sexo, procedencia, diagn&#xf3;sticos cl&#xed;nicos y hallazgos anatomopatol&#xf3;gicos.</AbstractText><AbstractText Label="RESULTADOS">El grado de concordancia fue leve (&#x3ba; = 0,30; IC95%: 0,21-0,42), lo cual coincide con lo reportado internacionalmente en instituciones de salud con una poblaci&#xf3;n de pacientes y disponibilidad de recursos diagn&#xf3;sticos similares. La discrepancia cl&#xed;nicopatol&#xf3;gica evidenciada seg&#xfa;n la clasificaci&#xf3;n de Goldman et al., modificada por Battle et al., fue del 57,3 % (47/82) correspondientes a discrepancias mayores, valor que se encuentra dentro de los limites esperados.</AbstractText><AbstractText Label="CONCLUSIONES">La ligera concordancia cl&#xed;nico-patol&#xf3;gica de las autopsias cl&#xed;nicas y las discrepancias se encuentran dentro del rango esperado. Lo anterior resalta la importancia de mejorar el diagn&#xf3;stico cl&#xed;nico y sindrom&#xe1;tico de las enfermedades de inter&#xe9;s en salud p&#xfa;blica</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="INTRODUCCI&#xd3;N.">La autopsia cl&#xed;nica es una ayuda fundamental para confirmar el diagn&#xf3;stico de enfermedades de inter&#xe9;s en salud p&#xfa;blica. Sin embargo, la concordancia cl&#xed;nico-patol&#xf3;gica no ha sido evaluada.</AbstractText><AbstractText Label="OBJETIVO.">Determinar la concordancia entre los diagn&#xf3;sticos cl&#xed;nicos y los hallazgos anatomopatol&#xf3;gicos de autopsias en una instituci&#xf3;n hospitalaria de tercer nivel.</AbstractText><AbstractText Label="MATERIALES Y M&#xc9;TODOS.">Se desarroll&#xf3; un estudio descriptivo, observacional, transversal y retrospectivo, en el cual se analizaron las autopsias practicadas entre el 2015 y el 2019. Las variables estudiadas fueron: edad, sexo, procedencia, diagn&#xf3;sticos cl&#xed;nicos y hallazgos anatomopatol&#xf3;gicos.</AbstractText><AbstractText Label="RESULTADOS.">El grado de concordancia fue leve (k = 0,30; IC<sub>95%</sub>: 0,21-0,42), lo cual coincide con lo reportado internacionalmente en instituciones de salud con una poblaci&#xf3;n de pacientes y disponibilidad de recursos diagn&#xf3;sticos similares. La discrepancia cl&#xed;nico-patol&#xf3;gica evidenciada seg&#xfa;n la clasificaci&#xf3;n de Goldman <i>et al.,</i> modificada por Battle <i>et al.,</i> fue del 57,3 % (47/82) correspondientes a discrepancias mayores, valor que se encuentra dentro de los limites esperados.</AbstractText><AbstractText Label="CONCLUSIONES.">La ligera concordancia cl&#xed;nico-patol&#xf3;gica de las autopsias cl&#xed;nicas y las discrepancias se encuentran dentro del rango esperado. Lo anterior resalta la importancia de mejorar el diagn&#xf3;stico cl&#xed;nico y sindrom&#xe1;tico de las enfermedades de inter&#xe9;s en salud p&#xfa;blica.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autopsia</Keyword><Keyword MajorTopicYN="N">diagn&#xf3;stico</Keyword><Keyword MajorTopicYN="N">patolog&#xed;a</Keyword></KeywordList><CoiStatement><b>Conflicts of interest:</b> The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>13</Day><Hour>13</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>15</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39531556</ArticleId><ArticleId IdType="pmc">PMC11781530</ArticleId><ArticleId IdType="doi">10.7705/biomedica.7097</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Navarro JM. La autopsia cl&#xed;nica. Beneficios relacionados con su pr&#xe1;ctica. Medisur. 2018;(16):719&#x2013;722.</Citation></Reference><Reference><Citation>Valdez-Mart&#xed;nez E, Arroyo-Lunag&#xf3;mez E, Landero-L&#xf3;pez L. Concordancia entre el diagn&#xf3;stico cl&#xed;nico y el patol&#xf3;gico por necropsias. Salud P&#xfa;blica Mex. 1998;(40):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">9567656</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivas-Moncada S. Caracterizaci&#xf3;n de la autopsia y los hallazgos cl&#xed;nicos en pacientes fallecidos con enfermedad oncol&#xf3;gica. Hospital Escuela Dr. Roberto Calder&#xf3;n Guti&#xe9;rrez, 2007-2015. Managua: Universidad Nacional Aut&#xf3;noma de Nicaragua; 2016. tesis.</Citation></Reference><Reference><Citation>Mart&#xed;nez-Portuondo AI, Armas-P&#xe9;rez L, Gonz&#xe1;lez-Ochoa E. El diagn&#xf3;stico por autopsia en Ciudad de La Habana como indicador de la calidad del programa de control de la tuberculosis: 1998-2002. Rev Esp Salud P&#xfa;blica. 2007;(81):221&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">17639689</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathirareuangchai S, Shimizu D. Reaffirming the value of the autopsy. Am J Clin Pathol. 2019;(152):377&#x2013;383. doi: 10.1093/ajcp/aqz045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqz045</ArticleId><ArticleId IdType="pubmed">31141603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijpers CCHJ, Fronczek J, van de Goot FRW, Niessen HWM, van Diest PJ, Jiwa M. The value of autopsies in the era of high-tech medicine: Discrepant findings persist. J Clin Pathol. 2014;(67):512&#x2013;519. doi: 10.1136/jclinpath-2013-202122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2013-202122</ArticleId><ArticleId IdType="pubmed">24596140</ArticleId></ArticleIdList></Reference><Reference><Citation>Val-Bernal JF. The current role of autopsy in current clinical practice. Med Clin (Barc) 2015;(145):313&#x2013;316. doi: 10.1016/j.medcli.2015.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2015.02.015</ArticleId><ArticleId IdType="pubmed">25851915</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rgesser MV, Camps D, Calafat P, Diller A. Discrepancias entre diagn&#xf3;sticos cl&#xed;nicos y hallazgos de autopsia. Rev Argent Anat Patol. 2011;(18):64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">21550929</ArticleId></ArticleIdList></Reference><Reference><Citation>Boada N, Vega L, Centeno M, Siminovich M, Weller G, Sasb&#xf3;n J. Discordancias entre diagn&#xf3;sticos cl&#xed;nicos y anatomopatol&#xf3;gicos en 99 pacientes fallecidos en una unidad de cuidados intensivos pedi&#xe1;tricos. Rev Argent Ter Intensiva. 2014;(31)</Citation></Reference><Reference><Citation>Correa YY, P&#xe9;rez MOB, Moya JAV. Correlaci&#xf3;n cl&#xed;nico-patol&#xf3;gica en fallecidos del Hospital Universitario Cl&#xed;nico Quir&#xfa;rgico Cmdte. Manuel Fajardo Rivero. Medicentro (Electron) 2019;(23):53&#x2013;58.</Citation></Reference><Reference><Citation>Valencia-Mart&#xed;nez JE, Rodr&#xed;guez-P&#xe9;rez L, Nieto-Andrade B. Discrepancia entre los diagn&#xf3;sticos cl&#xed;nicos y por autopsia en un hospital pedi&#xe1;trico de tercer nivel. Bol Med Hosp Infant Mex. 2006;(63):232&#x2013;240.</Citation></Reference><Reference><Citation>Castro-G&#xf3;mez D. Concordancia entre el diagn&#xf3;stico cl&#xed;nico y los resultados anatomopatol&#xf3;gicos de los ni&#xf1;os que fallecieron por neumon&#xed;a en la unidad de cuidado intensivo pedi&#xe1;trico de dos instituciones de la ciudad de Bogot&#xe1;. Bogot&#xe1;: Universidad Nacional de Colombia; 2015. tesis.</Citation></Reference><Reference><Citation>Barnhart HX. A review on assessing agreement. Wiley Stats Ref Stat Ref Online. 2018:1&#x2013;30. doi: 10.1002/9781118445112.stat01671.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781118445112.stat01671.pub2</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Reyes &#xc9;, Rubio-Romero JA, Gait&#xe1;n-Duarte H. M&#xe9;todos estad&#xed;sticos de evaluaci&#xf3;n de la concordancia y la reproducibilidad de pruebas diagn&#xf3;sticas. Rev Colomb Obstet Ginecol. 2010;(61):247&#x2013;255.</Citation></Reference><Reference><Citation>P&#xe9;rez JAD, Uribe MAM. Dise&#xf1;o, realizaci&#xf3;n y evaluaci&#xf3;n de un sistema de validaci&#xf3;n del rendimiento del ejercicio m&#xe9;dico basado en la autopsia en el Hospital Universitario de Santander 2010. MedUNAB. 2010;(13):65&#x2013;70.</Citation></Reference><Reference><Citation>Departamento Administrativo Nacional de Estad&#xed;stica (DANE)   Defunciones no fetales. 2013.  [May 21, 2023].  Available at:  http://www.dane.gov.co/index.php/estadisticas-por-tema/salud/nacimientos-y-defunciones/defunciones-no-fetales/defunciones-no-fetales-2013
.</Citation></Reference><Reference><Citation>Baquero-Villa MA. Muerte por establecer y muerte s&#xfa;bita: es cuesti&#xf3;n de enfoque. Colomb Forense. 2016;(4):27&#x2013;40. doi: 10.16925/cf.v4i1.1968.</Citation><ArticleIdList><ArticleId IdType="doi">10.16925/cf.v4i1.1968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornelas-Aguirre JM, V&#xe1;zquez-Camacho G, Gonz&#xe1;lez-L&#xf3;pez L, Garc&#xed;a-Gonz&#xe1;lez A, G&#xe1;mez-Nava JI. Concordance between premortem and postmortem diagnosis in the autopsy: Results of a 10-year study in a tertiary care center. Ann Diagn Pathol. 2003;(7):223&#x2013;230. doi: 10.1016/s1092-9134(03)00050-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1092-9134(03)00050-9</ArticleId><ArticleId IdType="pubmed">12913844</ArticleId></ArticleIdList></Reference><Reference><Citation>Botero MP, Carrascal E, Daza Y, Donado P. Concordancia entre el diagn&#xf3;stico cl&#xed;nico y hallazgos de autopsia en dos per&#xed;odos en el Hospital Universitario del Valle, Cali. Colomb Med. 2004;(35):139&#x2013;144.</Citation></Reference><Reference><Citation>Matta L, Barbosa MM, Morales-Plaza CD. Clinical profile of dengue in patients consulting a tertiary hospital in the city of Cali, Colombia, 2013. Biom&#xe9;dica. 2016;(36):133&#x2013;139. doi: 10.7705/biomedica.v36i1.2627.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.v36i1.2627</ArticleId><ArticleId IdType="pubmed">27622446</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Garc&#xed;a J, Pe&#xf1;aloza-Quintero RE, Amaya-Lara JL. Estimaci&#xf3;n de la carga global de enfermedad en Colombia 2012: nuevos aspectos metodol&#xf3;gicos. Rev Salud P&#xfa;blica. 2017;(19):235&#x2013;240. doi: 10.15446/rsap.v19n2.66179.</Citation><ArticleIdList><ArticleId IdType="doi">10.15446/rsap.v19n2.66179</ArticleId><ArticleId IdType="pubmed">30183967</ArticleId></ArticleIdList></Reference><Reference><Citation>Fares AF, Cury PM, Lobo SM. Clinical-pathological discrepancies in critically ill patients with difficult premortem diagnoses. Rev Bras Ter Intensiva. 2011;(23):442&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">23949457</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina E, Esteban A, Fern&#xe1;ndez-Segoviano P, Rodr&#xed;guez-Barbero JM, Gordo F, Frutos-Vivar F, et al. Clinical diagnoses and autopsy findings: Discrepancies in critically ill patients. Crit Care Med. 2012;(40):842&#x2013;846. doi: 10.1097/CCM.0b013e318236f64f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318236f64f</ArticleId><ArticleId IdType="pubmed">22001588</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>